36
MBA Program in Health Care Management 2015 RESUME BOOK Wharton

Wharton _ 2015 Resume Book

  • Upload
    my

  • View
    303

  • Download
    24

Embed Size (px)

DESCRIPTION

Wharton

Citation preview

Page 1: Wharton _ 2015 Resume Book

MBA Program inHealth Care Management

2015RESUME BOOK

Wharton

Page 2: Wharton _ 2015 Resume Book

ContentsProgram Description . . . . . . . . . . . . . . . . . . . . . . .4

Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5

Graduates . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-27

Internship Sponsors . . . . . . . . . . . . . . . . . . . . . . .28

Health Care Program Mentors . . . . . . . . . . . 29-32

Administration . . . . . . . . . . . . . . . . . . . . . . . . . .33

Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34-35

Thank you for your interest in the Wharton MBA Program in Health Care Management . For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management

The Wharton SchoolUniversity of Pennsylvania3641 Locust WalkPhiladelphia, PA 19104-6218

215 .898 .6861 | Fax 215 .573 .2157 email: aleszczc@wharton .upenn .edu

For information on the Wharton Health Care Management Alumni Association, visit www .whartonhealthcare .org

For detailed information on the Health Care Management Department educational programs, visit http://hcmg .wharton .upenn .edu/

Page 3: Wharton _ 2015 Resume Book

M .B .A . GraduatesThe University of Pennsylvania was founded by Benjamin Franklin in 1740 . Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution . As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education . Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine . The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874 . The world’s first psychological clinic was opened at Penn in 1896 .

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management . Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education . In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education .

Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research . The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual .

This brochure is provided to introduce you to the 2015 Wharton Health Care Management Program graduates .

We encourage you to consider these individuals for employment .

2015Health Care Management

3

Page 4: Wharton _ 2015 Resume Book

4

The Graduate Program in Health Care Management is a full-time two-year MBA curriculum offered by the Health Care Management Department of the Wharton School . The program, the principal educational effort at the Leonard Davis Institute of Health Economics, is designed to provide managerial and technical expertise to students interested in the health care management field . By combining the skills of the Wharton disciplines with sensitivity to the needs of health care providers and recipients, the Wharton MBA health care graduate can effectively manage the delivery of health services and products at all levels .

The Program has produced graduates who have chosen careers in hospitals and other medical institutions, pharmaceutical, biotechnology and medical device companies, financial services, entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government . Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations .

The Leonard Davis Institute of Health Economics (LDI) is an interdisciplinary center for research and education in the organization, financing, and delivery of health care . Through LDI, University of Pennsylvania faculty and staff work together on issues concerning health policy, health insurance, managed care, hospitals, corporations, pharmaceutical companies, and other health- related organizations . Established in 1967, the Institute appropriately bears the name of the late Leonard Davis, one of the foremost innovators in private health insurance in the United States . He was the founder of Colonial Penn Group, Inc ., a company that has pioneered in insurance for older Americans . Both Mr . Davis and Mrs . Sophie Davis were generous benefactors to the University of Pennsylvania, contributing basic support for the activities of the Leonard Davis Institute .

Program Description

Page 5: Wharton _ 2015 Resume Book

5

All students are required to complete the Wharton Management Core . The Wharton School’s core curriculum is designed to increase crossfunctional integration, extend global experience, strengthen leadership training, and introduce new courses on key management issues . The core curriculum provides groundwork in basic management disciplines: economics, finance, financial and cost accounting, management science, managing people and organizational design, marketing, operations management, the governmental and legal environment of business, statistics, and strategy .

Fixed Core: • Foundations of Teamwork and Leadership • Marketing Management • Quality and Productivity • Regression Analysis for Business • Microeconomics for Managers • Management Communication

Flexible Core:Accounting

• Financial Accounting or• Financial and Managerial Accounting or• Accelerated Financial Accounting

Finance: Corporate Finance• Corporate Finance or• Accelerated Corporate Finance or• Introduction to Corporate Finance

Finance: Macroeconomics• Macroeconomics and the Global Economic

Environment or• Introduction to Macroeconomics and the Global

Economic Environment

Legal Studies & Business Ethics• Responsibility in Global Management or• Responsibility in Professional Services

Management• Managing the Established Enterprise or• Managing the Emerging Enterprise

Marketing• Dynamic Marketing Strategy or• Strategic Marketing Simulations

Operations• Business Analytics or• Information Technology and Business Transformation or• Innovation or• Operations Strategy• Communications• Advanced Persuasive Speaking or• Advanced Persuasion and Data Display or• Pitching Your Business

Global Immersion Program The Wharton Global Immersion Program is an optional half-credit elective course that provides first-year students with an in-depth exposure to international business practices and first-hand insights into a foreign culture .

The Health Care Major Courses and Electives These courses promote an understanding of concepts, institutions, and issues involved in the organization, financing, and delivery of health services and products in the United States . Health care electives are selected consistent with individual career objectives and interests .

Required• Health Services System• Health Care Field Application Project

Electives• Comparative Health Care Systems• Financial Management of Health Care Organizations• Managed Care, Market Structure, and

Health Care Delivery• Health Business and Policy• Health Care Marketing• Healthy Policy• Legal Aspects of Health Care• Management and Economics of

Pharmaceutical and Biotechnology Industry• Medical Devices• Management of Health Care for the Elderly• E-Health: Business Models and Impact• Management of Health Care Services Businesses• Health Care Entrepreneurship• Private Sector Role in Global Health• Health Care Services Delivery:

A Managerial Economic Approach• Advanced Study Project

The Health Care Summer Internship The internship is a three-month management experience which provides the health care major an opportunity to work with a senior executive in an organization of particular interest to the student .

MBA ElectivesOpportunities are available for the health care major to pursue a second concentration in fields such as entre-preneurship, marketing, finance, or operations, or to pursue specialized knowledge in areas such as health care financing or within specialized segments of the health care industry including managed care organizations, hospitals, pharmaceutical and biotechnology companies, medical device companies, specialty services organizations, and long term care organizations . Graduate courses are available throughout the University .

CurriculumThe Wharton Management Core

Page 6: Wharton _ 2015 Resume Book

6

David [email protected] of Michigan, Ross School of Business, Ann Arbor, MIB .B .A ., High Distinction, Finance and Accounting, 2006

An opportunity to build successful health care businesses through an operational or strategic role.

Medtronic, Northridge, CAMarketing Intern, Summer 2014

Designed and initiated a plan to evaluate and address cost-driven attrition in the United States for the Diabetes Business Unit . Developed a consumables marketing toolkit that was showcased at an industry conference in August 2014 . Created the business case recom-mendation for launch of a new infusion set in early 2015 .

Soros Fund Management, New York, NYPrivate Equity Associate, 2010-2013

Member of the private equity group at Soros Fund Management, the private family office of the Soros family . As part of a 16-person team managing a $3 .5B portfolio, primary responsibilities were to evaluate new investment opportunities and to manage portfolio companies in a variety of industries including telecommunications, waste-to-energy and healthcare .

G.F. Capital Management and Advisors, New York, NYPrivate Equity Associate, 2007-2010

$250M private equity fund focused on media, entertainment, and branded consumer products . Evaluated and executed potential opportunities as the sole associate resource in the organization with responsibilities including: developing financial models, leading due diligence sessions, coordinating third-party advisors, and preparing investment memorandums .

Neil [email protected] of Maryland, College Park, MDB .S ., Biochemistry, B .S ., Mathematics, 2008Harvard Kennedy School of Government, Cambridge, MAM .P .A . Candidate, 2016

An opportunity to use my strategic and operational expertise to improve value in health care delivery.

Deloitte Consulting, New York, NYSummer Associate, Summer 2014

Advised a major foundation in setting organization-wide strategy for $300M in health-related funding and investment . Synthesized primary and secondary research into strategy white paper to be used by other large foundations .

Mount Sinai Hospital, New York, NYSummer Administrative Resident, Summer 2014

Recommended staff allocation modifi-cations that increased OR utilization by 30% . Pinpointed margin contribution from surgeries using financial and medical data . Analyzed ER care processes to reduce wait times and increase revenue .

Catapult Consultants, Arlington, VAHealth Care Analyst, 2011-2013

Worked with Medicare & Medicaid on multiple engagements targeting care quality in hospitals and nursing homes . Developed data analysis tools; supported IT system design; created client trainings . Only analyst invited to aid senior man-agement in new business development .

U.S. Peace Corps, Bondo, KenyaPublic Health Advisor, 2009-2011

Advised 4 rural hospitals on operational improvements and recommended changes to Health Ministry’s $1 .2M district budget . Created health education initiative reaching 2,500 students .

Matt R. [email protected] University, Providence, RIB .A ., Economics / Engineering, 2009

A commercial marketing opportunity in the biopharmaceutical industry.

Pfizer, New York, NYMarketing Summer Associate, Summer 2014

Led the development of a full, multi-channel, physician marketing campaign to announce the potential US approval of Palbociclib, one of Pfizer’s most highly anticipated new drug launches . Presented recom-mended content strategy to Business Unit Review Committee to gain align-ment on strategy from a regulatory perspective . Worked with a creative advertising agency to drive the execu-tion of individual tactics and presented proposed campaign directly to the President of North America Oncology .

Simon-Kucher & Partners, Boston, MASenior Consultant, 2012-2013Consultant, 2009-2011

Pricing and marketing consultant for clients in the pharmaceutical, biotech-nology, and medical device industries . Led project teams of 2-9 consultants on engagements providing clients with data-driven strategic recommendations on topics such as launch pricing, payer contracting, forecasting, customer segmentation, messaging strategy, distribution strategy, and patient assistance programs . Leveraged quantitative analysis techniques including multivariate regression, cluster analysis, and conjoint analysis to drive strategic recommendations . Presented reports and key recommen-dations to client teams, including senior management and C-level executives .

Page 7: Wharton _ 2015 Resume Book

7

An opportunity to develop and execute innovative strategies to improve health care ecosystems.

Booz & Company (nka Strategy&), New York, NYMBA Associate, Health Strategy Group, Summer 2014

Developed product and go-to-market strategy for the launch of a $5B consumer-directed business at a major health insurer . Determined company and product positioning through analysis of consumer data, competitive offerings, and market trends . Designed an interactive financial operating model for the future-state business .

Falcon Capital Partners, Philadelphia, PASenior Associate, 2009-2013

Managed merger and acquisition, strategic advisory, and growth financing assignments in the health care and information technology industries . Led investment analyses related to platform company investments on behalf of private equity clients, including Warburg Pincus and Parthenon Capital . Directly managed client relationships during several sell-side transactions, including advising clients on personal long-term goals and negotiating deal terms with clients and investors .

Morgan Joseph, Nashville, TNAnalyst, 2007-2009

Participated in the origination, analysis, and execution of merger and acquisition, fairness opinion, and general advisory assignments for clients in various industries, representing over $1B in value .

Jonathan P. [email protected] & Marshall College, Lancaster, PA B .A ., Cum Laude, Finance / Accounting, 2007

Brian P. [email protected] University, New Haven, CTB .A ., Political Science, 2007

The opportunity to build successful businesses through health care focused private equity investing.

Health Enterprise Partners, New York, NYSummer Associate, Summer 2014

Evaluated more than two dozen investment opportunities in healthcare services and IT sectors for firm’s $150M second fund . Transaction experience includes preferred equity investment in InDemand Interpreting, a provider of video remote interpretation (VRI) services to the health care provider market . Worked extensively with multiple portfolio companies to amend cash management strategy and forecast revenue bridge projections .

Self Health Network, San Francisco, CAChief Strategy Officer, 2013

Self Health Network is a readmission avoidance-focused health care technol-ogy company . Responsibilities included leading successful fundraising effort, cultivating sales pipeline, developing new product and preparing eight-quarter corporate strategic plan .

Bank of America Merrill Lynch, New York, NYAssociate, Health Care Investment Banking, 2010-2013

Provided financial, M&A and strategic advisory services to health care provider and managed care companies resulting in more than $1 .8B in completed transactions in 3 years .

Merrill Lynch & Co., New York, NYAnalyst, Tax-Exempt Capital Markets, 2007-2009

Originated and traded credit products for a Merrill Lynch proprietary fixed income trading desk as well as third-party clients .

Joshua [email protected] University B .A ., Economics and French Studies, 2008 Harvard Kennedy School of Government M .P .A . Candidate, 2016

An opportunity to build successful companies in healthcare through strategy, business development, or direct investing.

Albright Stonebridge Group, Washington, DCExternal Adviser, 2014

Advised multinationals on how best to navigate complexities of investments and operations in emerging markets through commercial diplomacy and management consulting . Focused on client service and business develop-ment for finance and health care sectors .

McKinsey & Company, Boston, MA Engagement Manager 2013 Senior Associate 2012 Business Analyst 2010-2012 Research Analyst 2008-2010

Led large consultant and client teams across over a dozen projects for lead-ing life sciences, financial services, and private equity firms . Worked closely and built relationships with senior client management across industries, geographies, and cultures . Designed and managed complex projects, creating client deliverables, conduct-ing qualitative and quantitative analysis, and coaching consultants and client executives .

World Economic Forum, Geneva, SwitzerlandProject Manager 2012

Developed strategies and policy rec-ommendations for Ministers of Health, Ministers of Finance, and industry leaders on health system delivery and financing . Facilitated CEO and Minister level discussions at the World Economic Forum Annual Meeting at Davos 2012 as well as 10 other half-day workshops .

Page 8: Wharton _ 2015 Resume Book

8

An opportunity in consulting with exposure to the healthcare sector.

Alyuta, Istanbul, TurkeyCustomer Development Manager, 2012-2013

Led a 4-person team to develop a cutting-edge marketing analytics tool for Turkey’s largest hospital chain and e-commerce companies . Analyzed client data and made recommendations based on customer lifecycle analytics, next-product-to-buy, and customer lifetime value models .

Pfizer, Istanbul, TurkeyProduct Manager, 2009-2012Project Manager 2008-2009

Responsible for developing and executing cardiovascular products’ business plans, including the cholesterol-lowering drug Lipitor . Developed launch plans for two different products (Eliquis, Sevikar) including regulatory, reimbursement, pricing, and market-ing strategies by working closely with cross-functional partners . Planned and coordinated co-promotion business models with Bristol-Myers Squibb and Daiichi Sankyo and led regular executive meetings with country managers of both companies to ensure high level alignment . Developed Turkey’s first telemedicine project empowering physicians to track patients’ records remotely . Devised sales transformation program for Norvasc (Turkey’s best selling anti-hypertensive), which resulted in 20% unit growth and $22M sales . Identified growth potential in diabetic patients for Lipitor by consoli-dating market data with customer insights and led diabetes projects resulting in increased treatment rates of diabetics .

Elif Ç[email protected] University, Istanbul, TurkeyB .A ., High Honors, Management, 2008

A promotional or strategic marketing opportunity focused on oncology/ hematology or rare disease within the biopharmaceutical industry.

Celgene Corporation, Summit, NJHematology Marketing Intern. Summer 2014

Evaluated and provided recommenda-tions for potential commercial partner-ships with companies filing NDAs for a drug to be used in combination with Revlimid . Spearheaded an evaluation of the current strategy for marketing to hematology/oncology NPs/PAs and recommended specific tactics, as well as increased spend/attention to this group . Used my commercial regulatory expertise to lead the creation, review, and ad agency collaboration for both consumer- and physician-focused promotional tactics .

Genentech Inc., South San Francisco, CAAssociate Program Director, 2008-2014

Worked for five years full-time and for one year on a contract basis as the promotional review committee (PRC) lead for multiple brands, including Boniva, Herceptin, Perjeta, Rituxan for RA, and Tarceva . Led the product launch for Perjeta and served as the main commercial regulatory expert for cross-functional teams, including PR, brand marketing, managed care, access solutions, medical affairs, corporate communication, commercial training, etc . Pioneered the “Creating Perspective” training program to teach sales representatives about the PRC process and evolution of brand mes-saging . The program was nominated for a RethinkD Award for out-of-the box thinking for the betterment of the company .

Alexandra C. [email protected] University, Bethlehem, PAB .S ., High Honors, Bioengineering, 2008

An opportunity to work at the intersection of healthcare and technology to improve patient outcomes.

Infosys Limited, Pune, IndiaIntern, Infosys Public Services, Summer 2014

Developed market-entry strategies to support Infosys’s expansion into the US healthcare and government sectors . Worked across sales, marketing, and product development divisions to modify existing IT solutions for US market needs .

Clinton Health Access Initiative Nairobi, Kenya & Kingston, JamaicaAssociate, Drug Access Team, 2011-2013Analyst, Jamaica Country Team, 2010-2011

Advised government officials in the Caribbean and Sub-Saharan Africa on opportunities to reduce HIV treat-ment costs and increase quality of care . Managed $3M grant covering programs and staff in Kenya, Uganda, Ethiopia, Tanzania, Nigeria, and Liberia . Collaborated with procurement agencies and regulatory authorities to accelerate the introduction of novel, life-saving commodities and mitigate impending stockouts of HIV drugs .

Accretive Health, Chicago, ILLead, Measurement Team, 2008-2010

Created complex financial models to quantify the value of Accretive’s revenue cycle initiatives . Improved accuracy of measurements allowed the company to invoice and collect on over $10M in outstanding revenue .

Colin W. [email protected] University of Chicago, Chicago, ILB .A ., Honors, Philosophy, 2007 Harvard Kennedy School, Cambridge, MAM .P .A . Candidate, 2016

Page 9: Wharton _ 2015 Resume Book

9

An opportunity in private equity with exposure to the healthcare industry.

Citadel Investment Group, New York, NYGlobal Equities Summer Associate, Summer 2014

Initiated coverage or made recommen-dations on five long/short positions . Developed detailed financial models to analyze potential investment opportunities . Conducted fundamental analysis through primary research; led discussions with executive manage-ment teams .

Galen Partners, Stamford, CTAssociate, 2011-2013

Healthcare private equity firm with approximately $1B AUM . Assessed and analyzed investment opportunities across a range of transaction types, including growth equity, leveraged buyout, and private investment in public equity; proactively sourced and screened investment opportunities . Successfully completed five new or follow-on investments and one portfolio company sale . Advised portfolio company management teams on strategic planning and business development .

Stifel Nicolaus Weisel, New York, NY / Baltimore, MDHealthcare Investment Banking Analyst, 2008-2011

Ranked in the top quartile of analyst class . Analyzed companies using comparable company, precedent transaction, leveraged buyout, and discounted cash flow analyses . Supported senior bankers in the procurement and execution of three M&A transactions, eight financings that raised in excess of $1B in equity and debt capital and one valuation assignment .

Dustin W.M. [email protected] Hopkins University, Baltimore, MDB .A ., Economics and Psychology, 2008

An operational, financial, or strategic transformation role with provider organizations transitioning to value-based care.

McKinsey & Company, Washington, D.C.Business Technology Associate, Summer 2014

In first study, conducted market scan and fit-gap-analysis for claims product solutions for $1B government project that client is pursuing . In second study, developed framework and identified target companies for $150M HIT purchasing strategy for payer client .

Center for Medicare & Medicaid Innovation, Washington D.C.Special Assistant to the Director, 2012-2013

Launched five payment programs worth $1 .5B under aggressive administration deadlines by negotiating technical and press details with senior leadership in HHS and the White House .

Center for Medicare & Medicaid Innovation, Washington D.C.Pioneer Accountable CareOrganization (ACO) Program Officer, 2011-2012

Received Administrator’s Special Citation Award for exceptional work as operational lead and program officer on Pioneer model . Served as sole Medicare representative to 10 major health systems . Co-led online peer learning networks on data analytics, risk stratification, and predictive modeling . Crafted alignment algorithm, beneficiary overlap, attestation, audit, program monitoring, and reinsurance policies . Negotiated terms of ACO contracts with nine health systems for combined worth of approximately $10B .

Alli [email protected] University, Cambridge, MA A .B ., Cum Laude, Government, 2010

An opportunity to apply my business and technical skill set to strategic and operational roles focused on leveraging technology to lower costs, improve quality and increase access to care.

Google, Mountain View, CA gTech MBA Intern, Summer 2014

Developed a model to conduct a global data analysis of Google’s tech-nology support team, providing the VP of Sales with strategic insights and recommendations related to product adoption, growth trends, and support capability gaps . Analyzed data to identify key drivers of unmet service metrics, implementing 4 initiatives that led to a 53% improvement in total resolution time .

Deloitte Consulting, Los Angeles, CA Consultant, 2009-2013

Primarily served health insurance clients across multiple projects in technology strategy from operations and process improvement to enter-prise-wide system migrations for the Health Insurance Exchanges . Delivered a deployment strategy for a newly acquired health care benefit manage-ment application, analyzing risks and benefits of 4 potential deployment options . Additionally, conducted a fit-gap analysis of the client’s customer service team to determine the operational impacts of using a new application . Identified technical infrastructure needs, process redesign opportunities and training requirements .

Daisy J. [email protected] of California, Berkeley, CAB .S ., Industrial Engineering & Operations Research, 2009

Page 10: Wharton _ 2015 Resume Book

10

An opportunity to apply my clinical, business, and research experiences to a strategic role in medical device innovation.

Becton Dickinson, Franklin Lakes, NJStrategic Innovation Intern, Medical-Surgical Systems, Summer 2014

Developed a business opportunity strategy in medical oncology to identify unmet clinical needs and managed a direct report with full-time dedication to my project .

Children’s Hospital of Philadelphia, Philadelphia, PAMedical Student Researcher, Cardiology, 2012-2013

Studied implanted medical devices modified to inhibit pro-inflammatory events . Selected for a presentation at the Scientific Sessions of the American Heart Association . Published manuscript in Biomaterials .

Hospital of the University of Pennsylvania, Philadelphia, PAMedical Student Researcher, Critical Care, 2012-2013

Conducted interviews and synthesized clinician surveys of a clinical decision support tool for sepsis . Refined system to result in a more sensitive alert . Selected for an oral presentation at the Mid-Atlantic Healthcare Bioinformatics Symposium .

Hospital of the University of Pennsylvania, Philadelphia, PAMedical Student Researcher, Interventional Radiology, 2010

Conducted clinical research on Hereditary Hemorrhagic Telangiectasia and central venous access devices . Selected for two presentations at European IR Society Conference . Published manuscript in the American Journal of Cardiology .

Katherine A.A. [email protected] College, Haverford, PAB .S ., Honors, Chemistry, B .S ., Mathematics, 2009Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM .D . Candidate 2015

The integration of my science and business backgrounds to make health care more accessible and affordable for patients.

McKinsey & Co., Palo Alto, CASummer Associate 2014

Managed the transformation of clinical trial operations for a global pharma-ceutical company . Oversaw several workstreams that planned and monitored outsourcing to a contract research organization .

Perelman School of Medicine, Philadelphia, PAGraduate Student Researcher, 2010-2014

Conducted analyses on risk factors for and outcomes after mandibular distraction osteogenesis, autologous breast reconstruction, and hernia repair, among other procedures .

Cyndi U. [email protected] of Pennsylvania, Philadelphia, PAB .A ., Summa Cum Laude, Phi Beta Kappa, Biochemistry, English, 2010M .S ., Chemistry, 2010Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM .D . Candidate, 2015

An entrepreneurial opportunity to address healthcare challenges via technology innovations.

Augmedix, San Francisco, CAMBA Intern, Summer 2014

Developed new platform strategy by engaging strategic hardware, software, content, and services partners . Initiated account development in Philadelphia metro region by pitching to 20+ health system CEOs, CIOs, CMIOs, etc . Designed and implemented hiring processes for 20+ engineering, operations, sales, and legal roles, doubling size of SF HQ .

Practice Fusion, San Francisco, CABusiness Development Intern, Summer 2013

Sized revenue opportunity for new data analytics business line at $15M in near-term business, projected to grow to $200M+ . Designed and tested analytics prototypes with 35+ external health IT, life sciences, and health provider executives .

Deloitte Consulting, San Francisco, CAConsultant 2011-2013Business Analyst 2009-2011

Strategy consultant for clients in provider, plan, life sciences, telematics, software, and consumer products industries . Assessed joint venture for integrated delivery network to develop artificial intelligence product with $107B global technology leader . Managed partnership development with $1 .4B voice recognition company . Modeled post-Health Reform market changes to determine future areas of growth for $8B US health plan . Used deliverables to co-develop a Health Reform Market Offering .

Kelly C. [email protected] University, Stanford, CAB .S ., Management Science and Engineering, 2009

Page 11: Wharton _ 2015 Resume Book

11

An opportunity to apply my cross- disciplinary background in engineering and business in a strategic role focused on developing innovative care models and disruptive innovations.

McKinsey & Co., Palo Alto, CASummer Associate, Summer 2014

Developed analytic models and recommended an investment plan for improving women’s health as a part of the strategy for a global health foundation .

Natera, San Carlos, CAProduct Manager, 2009-2013

One of the first employees at Natera, a diagnostics company focused on improving maternal and fetal health through genetic insights . Led cross-functional decision-making across engineering, marketing, and sales to develop a suite of prenatal genetic testing products . Managed workflows across a team of 12 to ensure products and strategy were executed effectively and within executive management and board expectations . Took insights from the field through sales calls, conference meetings, and grand rounds presentations to inform product strategy and align priorities across teams .

Jennifer A. [email protected] Tufts University, Medford, MA B .S ., Biomedical Engineering, 2008Brown University, Providence, RIM .S ., Engineering, 2009

An opportunity to identify, build, and transform market-leading companies.

Mount Kellett Capital Management, New York, NYSummer Associate, Summer 2014

Sourced, diligenced, and presented public and private equity and credit opportunities across healthcare, TMT, business services, and financial institu-tions . Led research process, including analysis of unit economics, structural growth/decline, and investment catalysts to formulate investment theses and assess risk/reward .

GTCR, Chicago, ILAssociate, 2010-2013

Originated and led $2B of private equity transactions in healthcare sector across 3 platforms, including top-performing investment in Fund IX (Actient Pharmaceuticals), GTCR’s first life sciences investment (Cord Blood Registry), and largest healthcare eq-uity investment (Sterigenics) . Identified attractive segments within healthcare sector, analyzed market attributes, constructed detailed financial models, orchestrated due diligence efforts, and participated in board meetings . Executed five proprietary acquisitions in 24 months to build Actient Pharmaceuticals from management start-up to successful sale ($645M) . Partnered with management team to acquire Cord Blood Registry and worked alongside CEO to evaluate strategic initiatives .

Moelis & Company, New York, NYAnalyst, Mergers & Acquisitions, 2009-2010

Merrill Lynch & Co., New York, NYAnalyst, Media & Telecom Investment Banking Group, 2008-2009

Nicholas Y. [email protected] University, Cambridge, MAA .B ., Cum Laude, History, 2008

Michael J. Cromwell, [email protected] of Michigan, Ann Arbor, MIB .A ./B .B .A, with High Distinction, Latin and Finance, 2008

An opportunity to build leading healthcare businesses through investment or management.

Castlight Health, San Francisco, CAStrategy Intern, Summer 2014

Analyzed 17 adjacent categories to inform buy/build/partner decision-making for newly public healthcare technology company . Performed research on third-party administrator industry to identify disruptive growth opportunities, and presented findings directly to CFO . Developed mergers and acquisitions template to serve as valuation screening tool .

Ascension Health Care Network, New York, NYDirector of Financial Planning and Analysis, 2012-2013

Directed due diligence processes for prospective hospital acquisitions with Oak Hill professionals, Ascension Health subject matter experts, and outside consultants . Created multi-hospital leveraged buy-out model to evaluate hospital consolidation opportunity with combined revenues of $1B+ .

Oak Hill Capital Management, New York, NYPrivate Equity Associate, 2010-2012

Performed due diligence, created financial models and assisted portfolio company managers for private equity firm with $3 .8B in latest fund . Executed transactions in home health (AccentCare), radiation oncology (Vantage Oncology), and hospital (Ascension Health Care Network) sectors .

Barclays Capital / Lehman Brothers, New York, NYHealthcare M&A Analyst, 2008-2010

Executed financial models to assess M&A transactions and capital structure alternatives .

Page 12: Wharton _ 2015 Resume Book

12

An opportunity to apply my clinical, research and business experiences to accelerate drug development for diseases with significant unmet needs.

Bristol-Myers Squibb, Plainsboro, NJMedical Strategy Intern, Summer 2014

Led initiative to identify data gaps and design strategic projects for company’s highest-selling oncology drug ($1 .4B in 2013) . Developed comprehensive plan to overcome insurer restrictions to oncology drugs . Identified a risk to immuno-oncology field and proposed risk-mitigation solutions .

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PAAdjunct Assistant Professor of Medicine, 2014-PresentMember, Center for Orphan Disease Research/Therapy, 2013-Present

Appointed faculty member in Division of Hematology/Oncology to conduct clinical research and lead an interna-tional study as Principal Investigator .

Castleman Disease Collaborative Network, Philadelphia, PACo-Founder & Executive Director, 2012-Present

Launched global initiative to accelerate drug development for Castleman disease . Published research that caused a paradigm shift in the model of pathogenesis . Established $4 .5M partnership with Janssen Pharmaceuticals to build a first-of-its-kind registry/ natural history study . Direct 12-member team and 23-member International Scientific Advisory Board .

David C. Fajgenbaum, [email protected] Georgetown University, Washington, DCB .S ., Magna Cum Laude, with Distinction, Human Sciences, 2007Oxford University, Oxford, UKM .Sc ., Public Health, 2008Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D ., 2013

An opportunity in a strategic or consulting role focusing on health care.

Janssen Biotech Inc., Horsham, PAExperience Commercial Leadership Program Intern, Summer 2014

Built and piloted specialty pharmacy provider (SPP) performance dashboards for 3 brands: Simponi UC, Stelara, and Zytiga . Developed and identified leverage points along the patient fulfillment process for oncology and immunology strategic imperatives by working with 4 external partners, 50 key stakeholders spread across 10 business units within Janssen .

Corum Inc., Taipei TaiwanSr. Marketing Executive, 2012-2013 Marketing Executive, 2010-2012

Spearheaded the company’s strategic plans, client management, legal processes, technical investments; set global marketing strategy/product positioning and segmentations, increased company profits by 400x in 2 years . Initiated and oversaw new sales channels and new product indications in North America, EU, Latin America, China and Japan, ultimately leading to an over 20x increase in US sales revenues in 2012 . Developed interna-tional business opportunities in 25 countries and planned 50+ product launches through global partnerships . Trained, reviewed, and supported 15 field sales reps and 30 distribution companies worldwide to establish 15 new Fortune 500 accounts, includ-ing L’Oreal, Unilever, and Limited Brands in one year .

Christine [email protected] of California, Los Angeles, CAB .S ., Biochemistry, 2007Columbia University, New York, NYM .A ., Biotechnology, 2010

An opportunity to leverage my combined skill set in medicine and management to improve health care delivery and patient outcomes.

University of Colorado, Department of Medicine, Aurora, COCo-Investigator, Summer 2014-Present

Implementing system changes via a multi-disciplinary, multi-hospital quality improvement initiative to improve the patient care handoff process .

United States Navy, Bethesda, MDENS, MC, USNR, 2011-Present

Medical education funded by the United States Navy Health Professions Scholarship Program (HPSP) . Upon graduation, will serve as an active duty physician in the United States Navy .

KBL Healthcare, New York, NYAssociate, 2007-2009

Sourced and evaluated potential transactions; communicated with senior management of prospective acquisitions; developed financial models; drafted letters of intent; prepared company and investor presentations; assisted in management of portfolio companies of KBL Healthcare Ventures

Banc of America Securities, New York, NYInvestment Banking Analyst,Healthcare Group, 2005-2007

Conducted qualitative and quantitative financial analyses for the healthcare services, medical technologies, and life sciences sectors for M&A, IPO, and capital raisings . Developed in-depth quantitative modeling and transaction experience .

Dean L. [email protected] Dartmouth College, Hanover, NHA .B ., Salutatorian, Summa Cum Laude, Government, 2006University of Colorado School of Medicine, Aurora, COM .D . Candidate, 2015

Page 13: Wharton _ 2015 Resume Book

13

An opportunity to work on a dynamic team within health care services, with responsibility for both clinical operations and near-term strategy.

DaVita Healthcare Partners, Denver, CORedwoods Summer Associate, Summer 2014

Led a project exploring upstream patient education opportunities within hospi-tals . Determined how new kidney patients are educated today on their choices while in the hospital, through extensive secondary research and a dozen hospital visits across the country . Designed two in-hospital patient education programs that are now being piloted .

The Bridgespan Group, Boston, MAConsultant, 2012-2013Senior Associate Consultant, 2011

Strategy consultant for non-profit clients, with a focus on public health . Worked with several public health foundations to define their five-year investment strategy at the enterprise and initiative levels . Mentored and managed two junior teammates and was recognized as a finalist for office-wide “Coach of the Year” award .

Bain & Company, Chicago, ILSenior Associate Consultant, 2010-2011Associate Consultant, 2008-2010

Strategy consultant across sectors, with healthcare clients in hospital services, pharmaceuticals, and claims administration . Project examples include cardiac service line and outpatient expansion strategies, merger integration, and process redesign for financial forecasting .

Jennifer L. [email protected] University, Washington, DCB .S .B .A ., Summa Cum Laude, Accounting, 2008

An opportunity to advance health care innovation through effective investment and strategic advisory.

Wells Fargo Securities, San Francisco, CASummer Associate, Healthcare Investment Banking, Summer 2014

Provided M&A advisory to specialty pharmaceutical, medical device, and biotechnology companies . Developed marketing materials, conducted dili-gence, developed presentation materials, and provided process updates to client during a sell-side divesture . Worked with a biotechnology company’s C-suite to perform diligence for a private placement, and draft S-1 for confidential IPO filing . Performed valuation analyses using public comparables, precedent transactions, and DCF .

Accenture, San Francisco, CAConsultant, 2010-2013; Analyst, 2007-2009

Advised healthcare, pension, and tech-nology firms on organization design, training needs, and communication development . Select engagements: 1) created a project plan to drive reorganization of Biomedical Technology and Philanthropy business units for a 29-hospital system . Negotiated biomed union contracts and directed relevant meetings with site management, hospital administration, and HR . Convinced 10 separate foundations to transfer funds to a consolidated account to achieve financial and managerial efficiencies; 2) engaged client executives across multiple business units to gain buy-in for an organization change strategy; 3) managed cross-border team to develop and deliver training courses to internal and external stakeholders of a public pension fund .

Danika M. [email protected] University, Stanford, CAB .A ., Sociology, 2007M .A ., Sociology, 2007

An opportunity to build successful healthcare businesses through growth equity investment and effective management.

Apple Tree Partners, Princeton, NJ / New York, NYSummer Associate, Summer 2014

Performed due diligence for two investments that closed in Aug/Sep 2014 as part of the firm’s $1 .67B fund: Series A in the opioid treatment space and Series B in the care coordination space . Developed healthcare IT investment thesis based on extensive literature and field research . Worked with an entrepreneur-in-residence in the planning stages of a population health management start-up .

Marwood Group, New York, NYAssociate, 2013Analyst, 2011-2012

Performed due diligence for private equity clients making healthcare investments . Advised on commercial / government payor reimbursement environments, legislative trends, and Medicare / Medicaid policy changes . Conducted primary and secondary market research for 100+ projects in numerous healthcare subsectors .

Boston Children’s Hospital, Boston, MAGenetics Researcher, 2009-2010

Conducted genetics research to understand the orphan disease of nemaline myopathy . Co-authored a paper published in a highly regarded genetics journal .

Zoe C. [email protected] Institute of Technology, Cambridge, MAB .S ., Physics, B .S ., Biology, 2009

Page 14: Wharton _ 2015 Resume Book

14

An opportunity to help lower middle-market healthcare services companies develop into industry leaders.

athenahealth, Watertown, MABusiness Development Intern, Summer 2014

Identified, researched, and assessed 200+ prospective healthcare technology partnerships/acquisitions as part of athena’s strategy to build out its inpatient revenue cycle and clinical software solutions . Met with manage-ment teams of 35 companies to evaluate their best-of-breed technology-enabled services . Presented analysis and recommendations on how select partnerships may support athena’s effort to address key hospital pain points .

Waud Capital Partners, Chicago, ILAssociate, 2011-2013

Evaluated and assessed control-oriented growth equity investment opportunities in healthcare, business, and consumer services out of the firm’s $463M Fund III . Collaborated with team of investment professionals to close one platform investment, five add-on acquisitions, and two portfolio company debt financings . Partnered with management teams of portfolio companies to create business strategy, assess and structure strategic acquisitions, access financing sources and develop corporate governance as a board observer .

Bank of America Merrill Lynch, New York, NYAnalyst, Mergers & Acquisitions Group, 2009-2011

Contributed to client acquisition strategy through financial analysis, valuation assessment, and company due diligence, resulting in four closed transactions .

Jeffrey S. [email protected] University, Cambridge MAA .B ., Cum Laude, Economics, 2009

An opportunity to apply my strategy experience to an operational role that gives patients access to quality services and/or devices.

Medtronic, Minneapolis, MNCorporate Strategy Summer Associate, Summer 2014

Developed growth strategy for Integrated Health Solutions to quintuple revenue by 2018 . Conducted deep dives in 6 European countries to understand how patients and money flow through each healthcare system in order to best position and commu-nicate value of Medtronic’s solutions portfolio .

Boston Consulting Group, Detroit, MIAssociate, 2010-2013

Enabled executives to solve key strategic issues . Projects led to the initiation of a hospital system merger ($7B combined revenue), sale of an auto supplier business unit ($500M revenue), consolidation of 31 equity portfolios ($40B AUM), and delayering ($20M savings) of a consumer goods company . Responsibilities included creating models, evaluating potential targets, market sizing, designing decision trees, developing strategic rationale, and communicating with executives .

Daniel E. [email protected] University, New Haven, CTB .A ., Economics, 2010

An opportunity to combine my clinical and business experiences to transform care delivery to improve quality and outcomes.

Kaiser Permanente, Oakland, CAPerformance Excellence Intern, Summer 2014

Developed metrics to measure end-of-life quality at KPNC hospice agencies . Conducted chart reviews and analyzed variations in cost and outcomes at KPNC medical centers to develop clinical best practices .

Becton-Dickinson Diagnostics, Franklin Lakes, NJStrategy and Development Intern, Summer 2014

Researched innovation thesis to serve the biobanking industry . Modeled costs, value creation potentials, and revenue potentials for major players in the sector .

AirCare, Philadelphia, PABusiness Associate, 2013-2014

Assisted in fundraising activities for AirCare, a health IT startup focused on developing a communications and remote monitoring platform to reduce hospital readmissions for patients with CHF .

The Boston Consulting Group, New York, NYSenior Associate Consultant, 2008-2010

Developed a brand revitalization plan for a biopharma in the nutritional space . Identified cost-savings opportunities in the post-merger integration of preclinical and PK/PD units of two biopharmas . Evaluated new product launch plans for a med-tech company, calculated an economic impact of $400M .

Jin [email protected] University, Princeton, NJB .S .E ., Magna Cum Laude, Phi Beta Kappa Chemical Engineering, 2008Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM .D . Candidate, Alpha Omega Alpha, 2015

Page 15: Wharton _ 2015 Resume Book

15

An investing role with exposure to health care.

Glenhill Capital, New York, NYSummer Research Analyst, Summer 2013

Identified and analyzed long/short equity investments in healthcare, industrials, and telecom at a bottom-up fundamental long/short equity hedge fund with $1 .6B AUM . Worked directly with Head of Research to execute and monitor 4 investments during 12-week internship .

Enhanced Equity Funds, New York, NYPrivate Equity Associate, 2010-2013

Contributed to all aspects of investment process at a healthcare private equity firm with $600M under management, which invests in lower middle market healthcare services companies . Participated in 15 transactions across 4 platforms and served on the Board of Primary Care Associates, a chain of primary care clinics acquired in 2012 .

Barclays, New York, NYHealth Care Investment Banking Analyst, 2008-2010

Covered companies across life sciences, healthcare services, and managed care . Contributed to several closed transac-tions, including Sole M&A advisory on Abbott’s acquisition of Solvay pharma for 4 .5B in 2012 . Ranked in top bucket during three out of four review cycles .

Miles [email protected] of Pennsylvania, Philadelphia, PAB .A ., History, 2007

An opportunity to build, grow, and improve health care through strategy or operations.

athenahealth, Watertown, MAAnalytics Strategy Intern, Summer 2014

Assessed athena’s analytics strategy for large enterprise clients and reviewed internal and external capabilities to meet anticipated demand . Built proof-of-concept reporting product, piloted prototype to hospital executives, and created roadmap for late 2014 implementation . Conducted client interviews, identified potential customer segments, and created internal sales message .

Amundsen Group – an IMS Health Company, Burlington, MASenior Associate Consultant, 2012-2013Associate Consultant, 2010-2012

Advised top 10 pharmaceutical companies on more than 15 projects focused on market access, marketing strategy, and pricing/reimbursement issues . Responsibilities ranged from client management to project management to heavy data analysis and modeling . Managed implementation of novel analytics process and led communication across multiple business units, tech divisions, and external vendors for multi-billion dollar respiratory portfolio . Analyzed marketing strategy and recommended initiatives focused on patient acquisition . Created new hire training program, led case simulations, and streamlined onboarding process for new hires, leading to a two-thirds reduction in training time .

Jonathan D. Hahn [email protected] Brown University, Providence, RI B .A ., Commerce, Organizations and Entrepreneurship, 2010

An opportunity to improve patient care through life sciences strategy.

Genzyme, A Sanofi Company, Cambridge, MABusiness Development Intern, Summer 2014

Led initiative to define Genzyme’s investment strategy in Multiple Sclerosis symptoms by prioritizing conditions and conducting a compre-hensive asset scan . Collaborated with R&D, Medical Affairs, Commercial Operations, and Market Access . Approach to be leveraged in multiple business units .

Leerink Swann, New York, NY Consulting Associate, 2011-2013Consulting Analyst, 2009-2011

Strategy consultant for pharmaceutical, biotechnology, medical device, and financial clients with life sciences assets . Experience includes creating a loss of exclusivity strategy for a global pharma client . Built complex modeling tool to assess economic impact of various pricing scenarios on key accounts, resulting in ~10% revenue increase . Managed a team of five on a group-wide initiative to improve efficiency and overall experience of consulting group .

Sanford C. Bernstein, New York, NY Research Associate, Summer 2008

Authored 35-page report on value of high-end consumer care products relative to low-end substitutes and impact on sector leaders during recession . This report was distributed to 200+ clients and presented in firm-wide meeting .

Seema A. [email protected] Harvard University, Cambridge, MA B .A ., Chemistry, 2009

Page 16: Wharton _ 2015 Resume Book

16

An opportunity to solve challenging financial, operational and strategy problems within health care.

Bank of America Merrill Lynch, Palo Alto, CASummer Associate, Technology Investment Banking, Summer 2014

Provided M&A Advisory for technology companies . Analyzed strategic acquisitions opportunities including redomiciling targets . Managed buy-side process and developed management presentations for a leading financial technology firm . Performed accretion/dilution and valuation analysis using public company comparables, precedent transactions, LBO, and discounted cash flow .

Harris Corporation, Washington, DCProject Manager, Dept. of Veterans Affairs, Veterans Health Benefit Enrollment Innovation Project, 2013

Reduced delays in the enrollment and processing of veterans’ health benefits by designing, testing and deploying improved software tools . Achieved 15 .3% ROS, exceeding management’s expectation of 12%, by effectively managing an 8 member team of analysts, software developers, and test engineers .

Business Development Manager, Healthcare Solutions Team, 2010-2013

Built and fostered my organization’s relationship with the US Coast Guard’s Medical Division and guided that relationship to an $11M contract award to provide our EMR installation and maintenance services . Engineered the technical specifications and features of a cloud-based electronic health record solution as a member of a multi-disciplinary team of engineers and medical specialists .

Roberto L. [email protected] of Florida, Gainesville, FLB .S ., Cum Laude, Computer & Electrical Engineering, 2007

An opportunity to operate and invest in innovative health care companies through venture capital or private equity.

Health Essentials LLC, Santa Ana, CAMBA Operations Intern, Summer 2014

Worked directly with the management team of the healthcare services venture-backed company . Collaborated with clinical, operations, IT, and finance as a project manager to launch dual eligible coordinated care product . Assessed population health software vendors and led RFP process .

Fidelity Biosciences, Cambridge, MASenior Analyst, 2012-2013Analyst, 2010-2012

Executed 16 new investments and 9 follow-on investments in biotech, medical device, healthcare IT, and healthcare services companies for a venture capital fund with $1B under management . Led strategic, technical, regulatory, market, and financial due diligence efforts . Invested in private startup companies (Series A – Series D) focused on healthcare IT, ultra-rare diseases, novel technologies in emerging markets, specialty hospitals, cancer, ophthalmology, dermatology, and hospital equipment . Served as board observer for two portfolio companies .

Leerink Partners, Boston, MAAssociate, 2009-2010Analyst, 2007-2009

Advised life sciences clients in over 20 consulting engagements in clinical development strategy, commercial opportunity assessments, M&A strategy, product life cycle manage-ment, and competitive landscape analysis .

Andrew D. [email protected] of Pennsylvania, Philadelphia, PAB .A ., Biological Basis of Behavior, 2007

A direct investing opportunity with exposure to the healthcare sector.

Putnam Investments, Boston, MAEquity Research Intern, Summer 2014

Conducted fundamental due diligence on public and private healthcare IT companies through product demonstrations, attending industry conferences, HQ visits, hosting company meetings, and expert calls; developed market and company models .

Clarion Healthcare, LLC, Boston, MAConsultant, 2013-2014Associate, 2010-2013

Advised a wide range of clients from biotechs to multinational pharmaceutical companies, contract sales organizations, medical device companies, and private equity and venture capital investors . Project work included due diligence / strategic transaction support (for manufacturers’ BD/New Products groups and PE/VC investors), sales force strategy and implementation, marketing innovation recommenda-tions, and managed care strategy . Focused extensively on the quality of care incentives that providers are facing as a result of healthcare reform and their implications for healthcare manufacturers and investors .

Elizabeth C. Hansen [email protected] College, Williamstown, MAB .A ., Cum Laude, Economics and Biology 2010

Page 17: Wharton _ 2015 Resume Book

17

An opportunity to build leading health care companies using my expertise in medicine and business.

Celgene Corporation, Warren, NJStrategy Intern, Summer 2014

Worked in a strategy role within Celgene Cellular Therapeutics (CCT), a wholly owned subsidiary of Celgene Corporation . Constructed long-range plan for Organ & Tissue Therapeutics division . Assessed next-generation opportunities for placental-derived regenerative medicine platform . Analyzed specific growth strategy for CCT’s umbilical cord blood bank, LifebankUSA .

HealthpointCapital, New York, NYIntern, Summer 2013

Performed clinical due diligence for $35M acquisition target, assessing technology’s efficacy and indications . Analyzed the competitive landscape, detailing competitors’ products, pricing, and market positions . Developed materials for and participated in Scientific Advisory Committee meeting regarding the acquisition .

Children’s Hospital of Philadelphia, Philadelphia, PAResearch Fellow, Summer 2011

Conducted clinical research in the Department of Neurosurgery resulting in poster presentation at annual American Association of Neurological Surgeons meeting and publication in Neurosurgery . Authored three textbook chapters on pediatric neurosurgical topics published in Pediatric Cancer, Spine Surgery Basics, and Neurosurgical Post-Operative Monitoring and Complications .

Michael J. [email protected] University, Durham, NCB .S .E ., Summa Cum Laude, Phi Beta Kappa, Biomedical Engineering, 2010Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM .D . Candidate, Alpha Omega Alpha, 2015

An opportunity requiring entrepreneurial and strategic thinking within the context of mobile health, companion diagnostics, or other disruptive forces with potential to make a significant impact on the health care industry.

Fitly, Philadelphia, PACo-Founder and CFO, Summer 2013-Present

Developed launch strategy, raised $210,000 in seed funding, established strategic partnerships, and launched the company . Designed/implemented supplier operating model in 2 stores in 2 months, establishing a delivery radius across 68 zip codes . Awarded admission into 3 competitive startup accelerator programs and won the Wharton Venture Award .

Booz & Company, Washington, DCSenior Consultant, 2013Consultant, 2011-2012

Strategy consultant for pharmaceutical, biotechnology, and payer clients with project experience in strategic launch planning, strategic capability assessment and design, companion diagnostics strategy, pipeline asset evaluation, post-merger integration, and commer-cial opportunity assessments in the digital/mobile health space .

Entre Todos (Microfinance Company), Buenos Aires, ArgentinaLoan Officer, Internal Consultant, 2009-2010

Worked as a loan officer with a portfolio of 70+ clients, developed/implemented client training programs to teach foun-dational business skills, and co-led the 6-month restructuring of a private microfinance firm .

Ford [email protected] Colorado College, Colorado Springs, COB .A ., Cum Laude, Philosophy, 2007

An opportunity to solve challenging problems in the health care industry.

McKinsey & Company, Atlanta, GASummer Associate, Summer 2014

Managed materials workstream on healthcare project that involved creating and monitoring a war room, tracking key process metrics, and implementing process improvements in order to assist the client in meeting critical product delivery dates .

Medtronic Spinal & Biologics, Memphis, TNSenior Product Development Engineer, 2010-2013

Designed and developed innovative instruments to facilitate the insertion of spinal implants by collecting and analyzing feedback from surgeons . Led cross-functional team on strategic projects to develop custom implants in order to improve the lives of patients and convince competitive surgeons to adopt Medtronic products . Completed the Medtronic Emerging Leader Program (participants are chosen through a rigorous selection process that identifies high performing employees) .

Covidien Neurovascular, Irvine, CAQuality Engineering Team Lead, 2008-2010

Managed team of engineers and technicians that provided focused quality support on micro catheters production lines . Implemented process improvements through the execution and timely closure of nonconformance reports, maintenance and analysis of statistical process control charts, and completion of process validations on new equipment and fixtures .

Luis M. [email protected] University, Stanford, CAB .S ., Biomechanical Engineering, 2006M .S ., Mechanical Engineering, 2008

Page 18: Wharton _ 2015 Resume Book

18

An opportunity to improve the quality, efficiency, and experience of patient care at an integrated health system.

Cedars-Sinai Health System, Los Angeles, CAMBA Intern, Clinical Transformation, Summer 2014

Led 15-member cross-disciplinary task force in developing the strategy and tactical roadmap for managing financial and clinical risk in new payer contracts . Designed pilot program for e-visits and presented recommendations to Medical and Clinical Directors to gain operational buy-in .

Monitor Group, Los Angeles, CASenior Consultant, Life Sciences, 2011-2013Consultant, Life Sciences, 2010-2011

Advised top 10 pharmaceutical, bio-technology, and medical device clients on marketing and organizational strategies . Developed various product positioning, segmentation, and physician messaging strategies for pre-launch and in-line products . Designed and launched a global Center of Excellence in access and reimbursement for a $15B biotechnology firm .

The Walt Disney Company, Burbank, CAFinancial Analyst, Business Planning & Development for Parks & Resorts, 2008-2010

Conducted financial modeling and due diligence research on potential acquisition targets in the travel and leisure sector . Led market sizing, profitability benchmarking analysis, and consumer segmentation for annual business line reviews with more than 20 finance and operations leaders .

Christina S. [email protected] Massachusetts Institute of Technology, Cambridge, MAS .B ., Brain and Cognitive Sciences, 2008

An opportunity in strategy and business development at a growth stage health-care services or technology company.

Quantia Inc., Waltham, MAStrategy and Business Development Associate, Summer 2014

Developed the go-to-market strategy for a new product targeting high-value medical technology companies and managed the initial sales team rollout . Created models to project the market size and value of additional physician members; presented to executive team and insights incorporated into fundraising strategy . Executed a segmentation of clients and identified opportunities to reprioritize sales, marketing and partnership targets .

InterbrandHealth, New York, NYSenior Consultant, 2013Consultant, 2011-2013Associate Consultant, 2008-2011

Managed brand development programs with cross-functional teams for 15+ clients across the healthcare industry . Programs ranged from product launches to mergers and acquisitions . Example projects include: creating the integration strategy for the merger of two medical device companies, coordinating the rollout of a new strategy for a diagnostic services company while growing the account from $600,000 to $2M, and consolidating a headache market segmentation to identify core prime prospects to achieve an $18M yearly growth target .

Jonathan M. [email protected] University, Atlanta, GAB .A . Psychology, 2008, Phi Beta Kappa

An opportunity to apply clinical and business knowledge to advance the quality of care patients receive.

Center for Surgery and Health Economics, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PAResearch Fellow, July 2013-Present

Performed outcomes research, primarily focused on endocrine surgery, and health services research . Received a research grant from the Society of American Gastrointestinal and Endoscopic Surgeons . Presented at national meetings . Multiple publications published in peer-reviewed journals .

Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PAResident in General Surgery, 2010-Present

Responsible for all aspects of pre-, intra- and post-operative care . Currently at the post-graduate year 5 level . Responsibilities include operating, daily patient care decision-making, and communicating with patients/ families . Responsible for leading the inpatient care team, including multiple junior residents and mid-level providers . Experienced in surgical critical care and cardiovascular surgical critical care . Experienced in diagnosis and treatment of vascular, thoracic, endocrine and oncologic, bariatric, colorectal, minimally invasive, trauma, and general abdominal surgery . Responsible for medical student teaching integrated into all aspects of clinical surgery .

Lindsay E.Y. Kuo, M.D. [email protected] Institute of Technology, Cambridge, MAB .S ., Biology, B .S ., Literature, 2006Northwestern University Feinberg School of Medicine, Chicago, ILM .D ., 2010

Page 19: Wharton _ 2015 Resume Book

19

An opportunity to pursue strategy and marketing to impact consumer health and nutrition within the retail sector.

Walmart eCommerce, San Bruno, CA@WalmartLabs Mobile Strategy Intern, Summer 2014

Evaluated mobile trends and features for Walmart to prioritize going forward . Assessed iPad app performance across the business portfolio to identify strengths and pain-points . Hosted business development meetings with entrepreneurs interested in partnering with Walmart in the mobile technology space . Conducted research across competitor mobile grocery apps to understand desired functionality in preparation for the Walmart To Go (grocery delivery) app launch .

Deloitte Consulting, New York, NYConsultant, 2010-2013

Provided strategic and managerial guidance for companies across both the health care and retail industries, with project work focused on customer and market insights . Sample projects: 1) performing a deep-dive on stake-holder influencers to improve provider targeting and segmentation for a pharmaceutical company; 2) enabling international growth initiatives by reprioritizing budget allocations and discretionary spend for a medical device company 3) analyzing consumer purchase habits and marketing effectiveness for an ecommerce retailer; 4) developing a predictive scorecard to enable store expansion for a global retailer .

Patricia J. [email protected] of Pennsylvania, Philadelphia, PAB .S ., Magna Cum Laude, Management & Operations Management, 2010

Ethan I. Lipkind, [email protected] University, Evanston, ILB .A ., Political Science, Slavic Studies, 2006Boston University School of Law, Boston, MAJ .D ., 2009

An opportunity to create value for healthcare businesses through private equity investing or strategy role.

Cressey and Co., Chicago, ILSummer Associate, Summer 2014

Engaged in all aspects of healthcare services investment processes including due diligence, modeling, and financing . Advised investment committee on healthcare services trends and sector opportunities, leading to 2 new invest-ment theses .

Complete Healthcare Management, Chicago, ILPrincipal, 2011-2014

Provide legal, compliance, and management services to physician practices and hospitals; sample transaction: formed multi-specialty group by merging neurosurgery and interventional radiology physician practices and launched stand-alone diagnostic medical imaging center to capture revenues from new group’s referrals .

Michigan Rural Healthcare Preservation Holding Co., d/b/a Michigan Clinic, Chicago, IL and MICEO, Director, 2009-2013

Managed over 400 employees . Oversaw operations and growth of health care provider holding company; responsible for all investment and corporate devel-opment decisions . Sourced, financed, structured, and executed acquisition of 2 community hospitals . Organized network affiliations with multiple physician practices, a research institute, and a medical school . Turned around hospital from perennial operating losses to highest net patient revenues and earnings in its 60-year history; doubled hospital assets, increased operating revenues 154%, decreased liabilities 45% .

An opportunity to grow a company in the wellness, nutrition or biopharma-ceutical sectors through a direct investing, strategy or operations role.

Biogen Idec, Cambridge, MANew Product Commercialization Intern, Summer 2014

As a member of the launch strategy team for an asset in Phase III, led a project to develop a strategy and identify tactics to improve the effi-ciency of diagnosis of a rare, neuro-muscular condition . Worked with cross-functional internal partners, sourced and managed external consultants, conducted primary research, and presented recommenda-tions directly to division Vice President .

Putnam Associates, Burlington, MASenior Consultant, 2012-2013Analyst, Associate, Senior Associate, Consultant, 2008-2012

Led strategic consulting projects for six top 15 pharmaceutical companies, and three top 10 biotechnology compa-nies . Areas of project focus include oncology, hematology, neurology, infectious disease, and health IT . Project responsibilities included creation of detailed forecast models, patient and physician strategic segmentation for marketing activities, design of payer contract terms, recommendation on tactics for engagement with patient advocacy, structuring pharmaceutical distribution contracts, and recommen-dations on clinical development plans . As a manager, trained, developed, and oversaw 30+ junior team members (~ 4-5 per project) .

Merck & Co., Rahway, NJAssociate Chemist, 2007-2008

Designed and synthesized over 100 novel small-molecule drug candidates based on structure-activity data and spectroscopic analyses . Contributed to patents for two drug candidate scaffolds .

David E. [email protected] University, Princeton, NJA .B ., Magna Cum Laude, Chemistry, 2007

Page 20: Wharton _ 2015 Resume Book

20

An opportunity to integrate my medical and business expertise to improve design of health care delivery systems.

University of Pennsylvania Health System, Philadelphia, PA; University of Pittsburgh Medical Center, Pittsburgh, PASub-Internships in Plastic Surgery, Summer 2014

Acting intern on plastic surgery service, treating patients, assisting in surgery across the spectrum of the plastic surgical field, including general recon-structive surgery, trauma reconstruction, breast reconstruction, craniofacial surgery, cosmetic surgery, and hand surgery . Active in clinical and basic science research .

Friends of NOAH, USA, Hershey, PACo-founder, Director 2009-Present

Friends of NOAH USA, (Nurturing Orphans of AIDS for Humanity), is a grassroots nonprofit designed to help communities raise their orphaned children by providing physical, educa-tional, and psychosocial support to the extended family network of children in South Africa who have been orphaned by AIDS . Co-ran the organization, built and ran online presence, organized annual fundraisers, researched and assessed our practices and outcomes . To date, we have raised over $120,000 and care for over 250 children .

Bain & Company, Chicago, ILAssociate Consultant, 2007-2009

As a strategy consultant, structured and performed analyses that drove impactful recommendations for Fortune 500 clients . Built financial models, assessed and recommended M&A targets, developed research tools, assessed and implemented executive culture and communication improvements .

Duncan [email protected] University, Durham, NCB .S ., Cum Laude, Neuroscience and Psychology, 2007Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM .D . Candidate 2015

An opportunity in pharma/biotech strategy analysis or health care consulting.

McKinsey & Company, Moscow, RussiaAssociate, Summer 2014

Worked with a client team to run analysis and develop opportunities to increase revenues .

TMK, Moscow, RussiaHead of Financial and Economic Analysis Department, 2011-2013

Led a team of analysts to perform analysis of economic and operational performance of the company with a $7B revenue for the needs of investors and management . Built valuation model for a company’s acquisition . Developed and implemented plan for a pre-acquisition debt restructuring .

Ernst & Young, Moscow, RussiaManager, 2005-2011

Led a team of auditors focused on serving pharmaceutical companies and healthcare providers . Awarded as a manager of the best audit project in 2010 . Achieved 25% reduction in the project time and 60% growth in the project’s profitability . Designed audit procedures that were included in the monthly emails distribution as best practices examples . Was elected by the company’s senior management to the board of experts .

Sofya [email protected] State University of Economics and Management, Novosibirsk, Russia, B .A ., 2005

An opportunity in management consulting or international business development focused in healthcare.

The Boston Consulting Group, Shanghai, ChinaSummer Consultant, 2014

Co-developed subsidiary role classifica-tion system and management guidelines for the governance of overseas subsidiaries for a leading global ICT solutions provider head quartered in China . Conducted benchmark study on foreign subsidiary management of 4 global technology conglomerates, presented findings to the head of Investment Management Department, and received high remarks .

B.Braun Medical, Beijing, ChinaKey Account Supervisor, 2012Senior Sales, 2010-2011

Developed sales strategies to increase market penetration, doubling sales revenue and market share of previous year . Designed key account manage-ment model to optimize resource allocation and created performance improvement initiatives to enhance sales team productivity . Received full score in annual performance evaluation with fast-track promotion and awarded “Best Sales”, “Early Bird”, “Key Account Management Champion”, and “Excellent New Employee” .

Johnson & Johnson Medical, Beijing, ChinaSales Management Trainee, 2009-2010

Managed sales at the largest cardiovascular hospital key account in China . Established strategic partnership with industry key opinion leaders and enhanced clients’ clinical expertise with physician education programs . Awarded “Best Project Execution” .

Wei (Lluvy) [email protected] University, Beijing, ChinaB .A ., History, 2009

Page 21: Wharton _ 2015 Resume Book

21

An opportunity to make an impact and create value through operational improvements.

Zalora, Jakarta, Indonesia Marketing Intern, Summer 2014

Designed and implemented new processes for promotional campaign development and customer relationship management teams, creating new roles, clarifying responsibilities, and introducing new incentive schemes . Developed segmentation for Zalora’s 200,000 customers in Indonesia based on identified main drivers of purchasing behavior and launched pilot to evaluate the effectiveness of newsletters tailored to customer preferences .

The Boston Consulting Group, Milan, Italy Associate, 2011-2013

Identified and launched strategic pricing initiatives in Germany, France, and Spain for major American medical device manufacturer as part of the redefinition of the go-to-market model leading to $25M bottom-line impact . Performed competitive analysis and quantitative assessment of the Italian Generics market in strategic due diligence on pharmaceutical company for top private equity firm . Defined new customer segmentation and targeting strategy for top European corporate and investment bank based on opportunities for cross-selling of high-value-added products resulting in $50M increase in revenues .

Deutsche Bank, Milan, Italy Investment Banking Intern, Fall 2010

Managed coverage activities on clients in the consumer, retail, industrial and healthcare sectors .

Carlo [email protected] University, Milan, ItalyB .B .A ., M .S ., Finance, 2011

An opportunity to develop and refine global pricing and market access strategies for select pipeline assets.

Biogen Idec, Cambridge, MAPricing & Reimbursement Strategy MBA Intern, Summer 2014

Led a project examining the financial and strategic impact of federally mandated 340B drug discounts on a pipeline asset, to inform U .S . launch planning . Supported the P&RS group by providing pricing estimates for an early-stage pipeline asset across three targeted indications, to inform indication prioritization and global commercial forecast . Helped manage an external vendor conducting primary payer research in U .S . and Germany, to understand value drivers and pricing potential for pipeline drug .

Deloitte Consulting, Boston, MAConsultant, 2012-2013Analyst, 2010-2012

Strategy and operations consultant focused primarily on pharmaceutical clients . Responsibilities included strategic advisement, analytical model development, process design, and project management . Major projects were: future-state design of global quality control processes within clinical trial data management; development of a U .S . brand planning tool to effectively manage marketing spend for client’s top 25 U .S . commercial drugs; and creation of business analytics to track effectiveness of a global data compliance project across 57 countries and 5 third-party vendors .

Kristen E. [email protected] Duke University, Durham, NCB .S ., Magna Cum Laude, Economics, 2010

An opportunity in strategy or business development at a biotech or pharmaceutical company.

Celgene Corporation, Summit, NJGlobal Marketing Intern, Summer 2014

Designed and executed an NPV analysis to assess commercial value of an internal asset and biomarker strategy in a large lymphoma indication . Worked closely with clinical team to design clinical trial scenarios to support development of asset . Analyzed development opportunity of a pipeline asset in a niche lymphoma indication not currently addressed, including review of treatment process and competitive landscape, and recom-mendation of how to optimize value of the asset . Created global messaging platform based on results of a ran-domized clinical trial and collaborated with US and global marketing leadership to validate and deliver messages .

ZS Associates, Boston, MAConsultant, 2012-2013Associate Consultant, 2010-2012Business Associate, 2008-2010

Sales and marketing strategy consultant for pharmaceutical, biotech, and medi-cal device companies . Managed teams of associates in conducting qualitative and quantitative market strategy engagements . Moderated qualitative interviews with physicians (across many specialties) and patients . Designed and analyzed quantitative research instruments to inform commercial strategy .

Amit A. [email protected] University, New Haven, CTB .A ., Psychology / Behavioral Neuroscience, 2008

Page 22: Wharton _ 2015 Resume Book

22

A health care finance role in banking, private equity or business development, leveraging my prior operational and strategic experience.

Raymond James, Nashville, TNAssociate, Summer 2014

Led teams in the execution of multiple M&A processes, the creation of mar-keting materials and the underwriting of $140M in capital raises for middle-market health care services businesses, primarily in the behavioral health and hospice industries .

CVS Caremark, Woonsocket, RISenior Analyst, 2011-2013

Designed and implemented a new chain-wide service guiding patients and doctors through the process of switching from a 30- to 90-day supply of select maintenance medications, increasing prescription drug adherence by 15% for converted patients and converting over 1M patients in first 12 months of program operation . Leveraged this capability to retain Walgreens patients during the Walgreens-Express Scripts dispute .

Monitor Company Group, Cambridge, MASenior Consultant, 2008-2011

Led teams in the creation of pricing, growth, and partnership strategies for a variety of corporations across the pharmacy, insurance, and pharma-ceutical industries . Examples include the creation of an econometrically- derived Medicare prescription drug plan pricing strategy for a national health insurer and prioritizing the development of pharmacogenomics revenue streams for a leading pharmacy benefits manager .

Gordon I. [email protected] College, Williamstown, MAB .A ., Math & Economics, 2008

An opportunity in strategy, operations, or business development to improve value in health care delivery.

Aetna Accountable Care Solutions, Hartford, CTProduct Strategy/Market Intelligence Intern, Summer 2014

Member of team forging innovative partnerships and insurance models with providers . Developed business case and new product concept for comprehensive at-home care solution to help providers lower the total cost of care . Created due diligence model to evaluate one of Aetna’s business strategies and the viability of a new solution in three markets .

The Advisory Board Company, Washington, DCSenior Analyst, 2012-2013Research Analyst, 2010-2011

Completed four best-practice research studies and several web conferences for a client base of 400+ senior hospital executives . Analyzed primary and secondary research into actionable strategies for hospital executives on topics including clinical quality perfor-mance, physician engagement and contracting, physician leadership development, ICU management, and use of advanced practice providers . Developed tools to help clients implement best practice strategies, including ROI analysis of palliative care and a toolkit for improving project management skills .

Lisa E. [email protected] University, St . Louis, MOB .A ., College Honors, Psychology, 2009

An opportunity to apply my medical and business experience to improve patient quality of care.

University of Pennsylvania Health System, Philadelphia, PAResearch Assistant, Department of Orthopaedic Surgery, 2011-2014

Critically examined precipitating factors for unplanned admission to the intensive care unit following arthroplasty . Spearheaded due diligence process in preparation for first published study, simultaneously laying ground-work for multiple subsequent studies, with ultimate goal of maximizing patient safety and clinical quality in joint replacement surgery .

Walter Reed Army Medical Center, Washington, DCResearch Assistant, Center for Neuroscience and Regenerative Medicine, 2009-2010

Investigated traumatic brain injury, spinal cord injury, phantom limb pain and other sequela of amputation . Participated in several original research projects by writing research protocols, participating in the Institutional Review Board process, and assisting with the execution of protocols .

Walter Reed Army Medical Center, Washington, DCClinical Research Assistant, Physical Medicine and Rehabilitation Service, Summer 2008

Treated multiple amputee patients with experimental mirror therapy designed to reduce phantom limb pain .

Caitlin L. [email protected] University, New Haven, CTB .S ., Cum Laude, Molecular Cellular and Developmental Biology, 2005University of Pennsylvania School of Medicine, Philadelphia, PAM .D . Candidate, 2015

Page 23: Wharton _ 2015 Resume Book

23

A direct investing opportunity with exposure to the healthcare sector.

Cornerstone Investment Partners, Atlanta, GASummer Associate, Summer 2014

Performed fundamental analysis of domestic equities for $9B fund . Constructed buy, sell, hold, and pass recommendations for 30+ stocks, and presented them to the portfolio managers .

Tiger Global Management, New York, NYAnalyst Intern, Spring Semester 2014

Worked 10-20 hours per week during the spring semester . Conducted primary research, reference checks and built financial models for equity investment ideas in various industries .

NCDR, LLC (dba Kool Smiles), Atlanta, GABusiness Development Manager, 2012-2013Senior Financial Analyst, 2010-2012

Led team of 7 during pilot and expansion of orthodontic program . Created pricing, roll-out, and capital spending strategies and presented recommenda-tions to executive management team . After receiving approval, grew program from pilot in 2 offices representing $200,000 of revenues to 14 offices representing $2M of revenues in 6 months .

Summit Partners, Palo Alto, CAAssociate, 2007-2009

Originated and executed healthcare private equity investments . Led reimbursement, market, regulatory, and financial due diligence efforts . Conducted primary interviews, wrote investment memorandums, and mod-eled deal return scenarios . Originated 11 Letters of Intent representing $1B of Summit Partners’ capital .

Matthew B. [email protected] Institute of Technology, Atlanta, GAB .S ., Highest Honors, Management, 2007

An opportunity to build and grow a health technology company.

Castlight Health, San Francisco, CAProduct Marketing Intern, Summer 2014

Partnered with the Product and Sales teams to develop collateral for recent and upcoming product releases . Drove the creation and operationalization of customer case studies in coordination with Sales Senior Leadership, Corporate Marketing, and Customer Success .

Omada Health, San Francisco, CABusiness Development Consultant, Summer 2013

Collaborated with Co-Founders, VP of Marketing, and VP of Sales to develop a multi-year business plan strategy: outlined sales process and target market, and developed pricing strat-egy . Assessed market competition and product positioning, and established strategic partnerships with wellness companies and benefits consultants to leverage synergies among product and service offerings .

Mercer, San Francisco, CASenior Associate, 2013Associate, 2011-2013Senior Analyst, 2010-2011Analyst, 2008-2010

Consulted self-funded employers (ranging from 2,000 to 150,000 employees) in solving major healthcare service, cost, and administration issues . Proposed solutions to address the short and long term implications of healthcare reform, and managed cross-functional teams of experts in law, pharmacy, and wellness as well as vendor account managers and implementation leads . Led the West Coast offices in Data Warehouse & Healthcare Analytics sales and implementations .

Emily T. [email protected] University of California, Berkeley, CAB .A ., Honors, Public Health, 2008

An opportunity to identify and build successful life sciences companies through a business development or investing role.

Genentech Inc., South San Francisco, CABusiness Development Intern, Summer 2014

Assisted deal teams in four licensing, acquisition, and collaboration deals by conducting scientific, legal and financial due diligence, drafting term sheets, and supporting negotiations in Immunology and Infectious Diseases spaces . Evaluated potential partnerships and deal structures to enable microbiome research and presented recommendations to senior leadership .

Frankel Group LLC, New York, NYSenior Associate, 2012-2013Associate, 2011-2012Analyst, 2010-2011

Provided strategic recommendations to guide pharmaceutical and biotech companies’ global R&D investments . Developed 9-year renal disease business strategy totaling $8B in revenue for Fortune 50 pharmaceutical company; analyzed market research and secondary data to develop $2B revenue model for immune-based renal diseases . Created investor presentation for a development stage biotech and collaborated with CEO to determine differentiating properties of novel drug and appropriate level of clinical data disclosure for a non-scientific audience . Led team in conducting 150 primary interviews targeting physicians, patients, and payers; synthesized findings to develop orphan disease business strategy for Fortune 50 pharmaceutical company .

Visali V. [email protected] Harvard University, Cambridge, MAA .B ., Cum Laude, Molecular & Cellular Biology, 2010

Page 24: Wharton _ 2015 Resume Book

24

An opportunity to improve the interactions among various stakeholders within the healthcare value chain.

Strategy& (formerly Booz & Company), New York, NYAssociate, Summer 2014

Analyzed network strategy at a major health insurer to achieve 15% medical cost saving for launch of a $5B consumer-directed business . Developed hypothesis and analysis framework for savings in Durable Medical Equipment, and Specialty Care Services .

SQZ Biotechnologies, Boston, MAMarketing Head, 2013-2014

Developed two-part marketing strategy: 1) Outbound marketing initiatives such as vendor shows that resulted in 30 active customers within first 8 months of operations; 2) Inbound marketing initiatives via SEO and customer analytics (impressions, click-through rate, and conversions), that resulted in 2x growth in traffic in 2 months .

Novartis Vaccines & Diagnostics, Raleigh, NCGlobal Value Chain Manager-Influenza Portfolio, 2011-2013Global Technical Leadership Program Associate, 2009-2011

Led planning, execution and issue management for portfolio comprising 6 influenza vaccine products accounting for 25% of revenue for the division . Managed cross-functional projects in supply chain, manufacturing, engineering, and finance across U .S .A ., U .K ., Italy, India, and Germany .

Ankit [email protected] Institute of Technology (IIT), New Delhi, IndiaDual Degree Bachelor and Master of Technology, Biochemical Engineering & Biotechnology, 2009

An opportunity with a hedge fund investing across the capital structure.

King Street Capital Management, London, UKSummer Associate, 2014

Generated investment ideas in the paper and packaging and European airlines spaces, presenting recommen-dations to the Investment Committee . Met with management teams and consulted industry experts to discover business risks and opportunities . Created detailed operating models and analyzed capital structure alternatives including rights offerings .

Taconic Capital Advisors, New York, NYAssociate, 2011-2013

Worked with fund Partners on distressed credit opportunities and long-short equity positions . Developed recovery model to determine value of unsecured claims at various entities in the American Airlines capital structure . Investigated Monster Beverage Corp’s convenience store sales strategy to model growth opportunity . Assessed widespread media reports regarding health hazards associated with energy drinks . Research led to a $50M equity long position .

The Blackstone Group, New York, NYAnalyst, 2009-2011

Collaborated with management teams of automotive and insurance companies to create financial models and business plans for corporate restructurings . Formulated strategies to negotiate with stakeholders and regulators .

J.P. Morgan, New York, NYAnalyst, 2007-2009

Performed credit reviews for J .P . Morgan’s technology, media, and tele-communications loan portfolio . Wrote a weekly update for report to CEO on restructuring situations .

Alexander V. [email protected] College, Hanover, NHA .B ., Summa Cum Laude, Chemistry and Psychology, 2007

An opportunity to improve healthcare delivery through innovations in care management, informatics, patient engagement, data connectivity, and insurance programs.

Aetna Accountable Care Solutions, Boston, MAProduct Strategy Intern, Summer 2014

Developed product concept to support accountable care organizations, including recommendations for tech-nology utilization, partnerships, and implementation; supported development of external partnerships designed to enhance accountable care organizations .

The Advisory Board Company, Washington, DC / Austin, TXDedicated Advisor, Performance Technologies, 2011-2013

Worked on a team that launched a new business intelligence tool designed to empower a data-driven approach to physician network development; analyzed large data sets, developed work plans, and provided execution support for program improvements .

Associate, Analyst, & Senior Analyst, Research & Insights, 2008-2011

Developed hospital strategies for clinical technology adoption and specialty program development; used pro-forma modeling to inform technology and infrastructure investments; led a team specializing in minimally invasive surgery, obesity, and chronic disease manage-ment .

Wharton Center for Health Management & Economics, Philadelphia, PAResearcher, 2007-2009

Explored success and failure of venture capital-funded healthcare companies; published article in Health Affairs, January 2009 .

Charlie A. [email protected] of Pennsylvania, College of Arts & Sciences, Philadelphia, PABA, Cum Laude, English, 2008

Page 25: Wharton _ 2015 Resume Book

25

A role blending strategy and operations for a provider focused healthcare IT solution.

Valence Health, Chicago, ILProduct Definition Intern, Summer 2014

Established standard operating procedures for demonstrating suite of health provider IT products to customers . Wrote requirements documentation for development of 5 new product features leveraging Agile process . Supported upcoming product user experience overhaul, including development of user personas and interface redesign .

Navigant Consulting Life Sciences Advisory Services, New York, NY / San Francisco, CAAssociate Director, 2013Managing Consultant, 2010-2013Senior Consultant, 2009-2010

Commercial and business development consultant for life sciences organizations . Managed internal teams and external relationships for up to 8 concurrent client engagements . Launched San Francisco office as day-to-day leader; integral in growth to 7 employees and ~10% of practice’s revenues within first year . Led multiple long-term client relationships, encompassing multiple follow-on projects .

ZS Associates, New York, NYAssociate Consultant, 2007-2009Associate, 2005-2007

Provided sales and marketing strategic advice to top pharmaceutical and biotechnology companies . Managed client relationships and internal project teams as large as 5-6 employees globally and officially mentored 3 junior employees .

Adam R. [email protected] of Pennsylvania, Philadelphia, PAB .S .E, Magna Cum Laude, Bioengineering, 2005

An opportunity to help build an innovative health care company through a business development role.

J.P. Morgan, San Francisco, CASummer Associate in Health Care Investment Banking, Summer 2014

Advised clients in the biotechnology, medical devices and diagnostics indus-tries . Performed financial analyses in-cluding DCF and trading comparables for an $80M private placement round for an innovative diagnostics company . Performed sum of the parts DCF valua-tion as part of a defense strategy for an $8 .9B biotechnology company . Led the creation of a buy-side M&A ideas pitchbook, conducting due diligence on over 30 potential acquisition targets for a $1 .2B biotechnology company .

Life Technologies, San Diego, CA & London, UKAssociate to the Chief Medical Officer, 2012-2013

Part of a clinical team tasked with identifying target areas for product development . Worked with R&D team to build models to identify target biomarkers, leading to the creation of 3 oncology panel tests used by a number of academic medical centers . Led the development of a clinical marketing campaign for the compa-ny’s first appearance at the ASCO .

National Health Service, London, UKSenior house physician (resident) 2009-2011

Prioritized, diagnosed, and treated inpatient admissions across a variety of specialties in internal medicine and general surgery . Delivered clinical results while working to tight deadlines in a highly pressured environment .

Bedir W. Shather, [email protected] of Leeds Medical School, Leeds, UKM .D ., 2009Imperial College London, London, UKB .Sc . Medical Sciences and Management, 2007

An opportunity with a private equity fund investing in the healthcare sector.

Teladoc, Greenwich, CTMBA Associate, Summer 2014

Constructed business plan and projection model for a contemplated behavioral health product offering . Assessed acquisition opportunities and evaluated new revenue models . Sourced potential investors and negotiated term sheets for Series F fundraise .

Altaris Capital Partners, New York, NYAssociate, 2011-2013

Assessed and executed new healthcare acquisition opportunities . Drafted transaction documents, arranged debt financing, managed diligence work flow, and built investment models . Monitored existing portfolio companies by attending board meetings, performing valuation analyses, and reviewing strategic opportunities with management . Assisted in fundraising process for Altaris’ third fund . Closed four deals including two LBOs, one add-on, and one exit .

Leerink Partners / Merrill Lynch, New York, NYAnalyst, 2008-2011

Analyzed equity, equity-linked and debt financing alternatives, merger consequences, private equity invest-ments, and IPO scenarios for compa-nies across the healthcare industry . Joined a group of over 20 investment bankers from Merrill Lynch who assumed leadership of the investment banking platform at Leerink Partners . Closed four deals including three M&A transactions and one equity offering .

Matthew L. [email protected] Mellon University, Pittsburgh, PAB .S ., University Honors, Business Administration (Finance), 2008

Page 26: Wharton _ 2015 Resume Book

26

An opportunity to further innovation in healthcare technology, whether as an investor or operator.

Longitude Capital, Menlo Park, CASummer Associate, Summer 2014

Built the foundation and investment strategy for the $710M firm’s newly-formed health IT vertical . Created and executed a thesis-based deal sourcing effort by mapping the sector, its themes, and its 1,000+ companies . Established the vertical’s advisory network of 20+ former entrepreneurs, industry leaders, and investors . Proactively sourced 8 investment opportunities and performed due diligence . Worked directly with partners and managed two junior interns .

Safeguard Scientifics, Wayne, PAAssociate, 2011-2013

Performed 8 venture capital deployments and an exit totaling $850M+ in transaction value in biopharma, medtech, diagnostics, and health IT . Performed due diligence on investment opportunities . Drafted investment memos and term sheets . Built financial models and cap tables . Rebuilt the firm’s backbone capital deployment and returns model . Worked with leadership of portfolio companies on strategic projects .

EuroConsult, New York, NYAssociate, 2009-2011

Led cross-border M&A transactions for private equity and Fortune 500 clients in pharma and medtech . Managed a team of analysts .

Citigroup, London, UK / New York, NYAnalyst, 2007-2009

Active participant on deal teams originating and executing M&A transactions in the healthcare sector across the U .S ., European and emerging markets .

Daniel P. van den [email protected] University, Ithaca, NYB .S ., Biological Engineering, 2007

An opportunity to research and evaluate investments in public and private health care companies.

Valo Group, Philadelphia, PAInvestment Analyst Intern, Summer 2014-Present

Evaluated equity and credit invest-ments in both health care and retail companies for value-oriented, long / short hedge fund . Performed market sizing, researched SEC filings and built detailed financial models to inform analyses and provide recommenda-tions directly to portfolio manager .

Deloitte Corporate Finance (Health Care & Life Sciences Practice), New York, NYVice President, 2011 – 2013Associate, 2008 – 2011Analyst, 2006 – 2008

Provided financial advisory services to public and private health care clients regarding mergers, acquisitions, divestitures/carve-outs and joint ventures . Led deal team in advising not-for-profit health care system ($7B Revenue) in execution of multiple acquisitions and joint ventures (e .g . surgery centers, radiology, radiation oncology, dialysis, anesthesia, and group physician practices) .

AT&T Corporate, Financial Leadership Program, Bedminster, NJCorporate Finance Specialist, 2005-2006Associate, 2004-2005

One of seven undergraduates recruited nationwide for executive development program with rotational assignments . Strategic Venture Fund – Built valuation models and evaluated startup companies as potential invest-ments for AT&T’s venture capital fund . Corporate Strategy - Supported Director in analyzing business models around new, confidential media technologies for CEO, David Dorman .

Tejus B. [email protected] University – School of Management, Boston, MAB .S ., Magna Cum Laude, Business, 2004

An opportunity to build successful businesses through health care focused private equity investing.

NaviMed Capital, Washington, DCSummer Associate, Summer 2014

Worked with founding partner of healthcare-focused growth equity fund to manage due diligence process for an investment in the roll-up of several healthcare services companies . Built financial model, developed financing materials to raise capital and worked directly with management teams . Researched industry landscape, identifying 20+ investment opportunities .

HarbourVest Partners, Boston, MADirect Investment Associate, 2011-2013

Sourced, evaluated and monitored growth equity, buyout, and mezzanine private equity investments for Direct Investment Group with ~$1 .5B dedicated capital . Evaluated 150 new opportunities and performed due diligence, created financial analyses and presented 13 prospective investments to Investment Committee, gaining approvals for 5 initial investments (1 healthcare services company) . Active board involvement on 3 portfolio companies . Completed 2 follow-ons and refinancing for ReCommunity, creating the largest independent recycling company in the U .S .

Wells Fargo Securities, Charlotte, NCHealthcare Investment Banking Analyst, 2009-2011

Top 10% of analyst class . Analyzed companies using comparable company, discounted cash flow, accretion/dilution, merger and leveraged buyout analyses for M&A transactions and debt and equity financings for life sciences companies .

Laura G. [email protected] College, Davidson, NCB .A ., Economics, 2009

Page 27: Wharton _ 2015 Resume Book

27

An opportunity focused on innovation in health care delivery, particularly at the point of service, with experience in big data analytics, supply chain, clinical and non-clinical process improvement, and revenue cycle.

The Children’s Hospital of Philadelphia, Philadelphia, PASummer Intern, 2014

Worked with the VP of Medical Affairs to develop a program for physician leadership education, including a needs assessment, content design, delivery model, and communication strategy . Worked collaboratively to integrate the perspectives of a comprehensive variety of stakeholders throughout the academic medical center, ranging from nurse and physician staff to the senior leadership team .

athenahealth, Watertown, MASenior Manager, 2011-2013

Supported senior leadership team as strategic subject matter expert on revenue cycle big data performance measurement, analysis, and reporting across athena client base representing over 50,000 physicians . Delivered performance improvement reports, including implementation plans and detailed impact projections to organizations ranging from 2-physician practices to 93-hospital health systems .

Huron Consulting Group, Chicago, ILManager, 2006-2011

Delivered supply chain, materials management, and strategic sourcing cost management strategies to senior leadership teams at client health systems ranging from single hospitals to 70- facility national healthcare institutions . Conducted cost savings strategies worth as much as $65M annually recurring savings, including identifica-tion, assessment, implementation, and ongoing monitoring efforts .

Rada [email protected] of Chicago, Chicago ILAB Fundamentals: Issues & Texts, 2006

An opportunity in strategy or business development to bridge developed and emerging markets in the healthcare industry.

Novartis AG, Basel, SwitzerlandMBA intern, Corporate Strategy, Summer 2014

Helped with 5-year strategic planning across all divisions and geographies in Novartis . Coordinated a global project on real-world outcomes across US, Brazil, UK and Germany . Analysis influenced senior decision making, changed forecast, and shifted spending .

McKinsey & Company, New York, NY / Shanghai ChinaAssociate, 2013Business Analyst, 2010-2012

Distinctive analyst directly promoted to Associate and the only transferee from Greater China to the US in 2012 . Focused on multinational pharmaceutical companies . Key projects included commercial excellence (e .g ., sales force effectiveness, marketing strategy), business development (e .g ., M&A target screening, licensing), and emerging market strategy (e .g ., entry and expansion strategy, local partnership) . Extensive field experience with sales representatives and physicians .

Ying [email protected] University, Shanghai, ChinaB .A ., Economics, B .A ., Law, 2007M .A ., Economics, 2010

A direct investing opportunity with exposure to the healthcare sector.

Fidelity Investments, Boston, MASummer Equity Analyst, Summer 2014

Performed fundamental equity analysis on domestic stocks in the retail sector . Constructed buy/sell recommendations for four stocks and pitched them to portfolio managers . Developed and presented industry overview presentation of discount retail sector to portfolio managers and President of Equity Division .

PAR Capital Management, Boston, MASummer Analyst, Summer 2013

Member of investment team at long-short equity hedge fund with over $3 .5B in assets . Constructed financial models and performed detailed analyses by developing bottom-up forecasts to assess sensitivity to key drivers and to identify upside/downside potential of investment opportunities .

Putnam Associates, Boston, MAConsultant, 2009-2013

Advised leading pharmaceutical and biotech clients on growth strategies, therapeutic area strategies, and pricing and reimbursement strategies, in both international and domestic markets . Constructed financial models and Monte-Carlo simulations to forecast value of pricing and contracting strategies, potential biosimilar competition, and impact of generic competition . Awarded 2011 Putnam MVP honor as distinction of top performance out of all employees .

David S. [email protected] University, New Haven, CTB .A ., Economics, 2009

Page 28: Wharton _ 2015 Resume Book

28

The following organizations provided internships for Health Care Management Students in Summer, 2014.

AETNA ACCOUNTABLE CARE SOLUTIONSBoston, MAHartford, CT

ALBRIGHT STONEBRIDGE GROUPWashington, DC

APPLE TREE PARTNERSPrinceton, NJ

ATHENAHEALTHWatertown, MA

AUGMEDIXSan Francisco, CA

BANK OF AMERICA MERRILL LYNCHPalo Alto, CA

BECTON DICKINSONFranklin Lakes, NJ

BIOGEN IDECCambridge, MA

BOOZ & COMPANY (NKA STRATEGY&)New York, NY

THE BOSTON CONSULTING GROUPShanghai, China

BRISTOL-MYERS SQUIBBPlainsboro, NJ

CASTLIGHT HEALTHSan Francisco, CA

CEDARS-SINAI HEALTH SYSTEMLos Angeles, CA

CELGENE CORPORATIONSummit, NJ

CELGENE CELLULAR THERAPEUTICS Warren, NJ

THE CHILDREN’S HOSPITAL OF PHILADELPHIA

Philadelphia, PA

CITADEL INVESTMENT GROUPNew York, NY

CORNERSTONE INVESTMENT PARTNERSAtlanta, GA

CRESSEY & CO.Chicago, IL

DAVITA HEALTHCARE PARTNERSDenver, CO

DELOITTE CONSULTINGNew York, NY

FIDELITY INVESTMENTSBoston, MA

FITLYPhiladelphia, PA

GENENTECH INC.South San Francisco, CA

GENZYME, A SANOFI COMPANYCambridge, MA

GLENHILL CAPITALNew York, NY

GOOGLEMountain View, CA

HEALTH ENTERPRISE PARTNERSNew York, NY

HEALTH ESSENTIALS LLCSanta Ana, CA

HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA, CENTER FOR SURGERY AND HEALTH ECONOMICS

Philadelphia, PA

INFOSYS LIMITEDPune, India

JOHNSON & JOHNSON – JANSSEN BIOTECH INC.

Horsham, PA

J.P. MORGANSan Francisco, CA

KAISER PERMANENTEOakland, CA

KING STREET CAPITAL MANAGEMENTLondon, UK

LONGITUDE CAPITALMenlo Park, CA

MCKINSEY & COMPANYPalo Alto, CAWashington, DCAtlanta, GAMoscow, Russia

MEDTRONICNorthridge, CAMinneapolis, MN

MOUNT KELLETT CAPITAL MANAGEMENTNew York, NY

NAVIMED CAPITALWashington, DC

NOVARTIS AGBasel, Switzerland

PFIZERNew York, NY

PUTNAM INVESTMENTSBoston, MA

QUANTIA INC.Waltham, MA

RAYMOND JAMESNashville, TN

TELADOCGreenwich, CT

UNIVERSITY OF COLORADO, DEPARTMENT OF MEDICINE

Aurora, CO

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

PHILADELPHIA, PA

UNIVERSITY OF PITTSBURGH MEDICAL CENTER

Pittsburgh, PA

VALENCE HEALTHChicago, IL

VALO GROUPPhiladelphia, PA

WALMART ECOMMERCESan Bruno, CA

WELLS FARGO SECURITIESSan Francisco, CA

ZALORAJakarta, Indonesia

Internship Sponsors2014

Page 29: Wharton _ 2015 Resume Book

29

SEBASTIAN AGUILAR GARCIAAssociateA .T . KearneyMexico City, Mexico

SHEENA ASHOKSenior ConsultantKaiser Permanente-Southern California Permanente Medical Group (SCPMG)Pasadena, CA

VIKRAM D. BAKHRU, MDChief Medical Officer First OpinionSan Francisco, CA

TONY BALDAPresident & COOMedicomp, Inc .Melbourne, FL

JOHN BARKETTDirector of Product Marketing and Policy Affairs Towers Watson Exchange SolutionsWashington, DC

MEGAN UNTALAN BARKETTChief of Staff to CEOThe Advisory Board CompanyWashington, DC

PETER R. BARNETT, DMDPresidentStar Ranch DentalPlano, TX

GRANT BECHTOLDVice President of Business Operations / Corporate DevelopmentMedsurant Holdings, LLC (portfolio company of New Capital Partners)Denver, CO

JAMIL BEGDirector, Business DevelopmentSage Therapeutics, Inc .Cambridge, MA

ALI BEHBAHANI, MDPartnerNEAChevy Chase, MD

ERIC BELLSenior DirectorIntellectual VenturesSeattle, WA

RYAN BERGERSenior Business AnalystHearst Health Innovation LabLos Angeles, CA

ALEXIS BERNSTEINDirector, Strategy & Operations, Accountable Care SolutionsAetnaBoston, MA

DEEPA BHATProduct ManagerGenentechSouth San Francisco, CA

MITCHELL BLUTT, MDCEOConsonance CapitalNew York, NY

DANIEL BRANCOFounder & CEODMBranco Healthcare Investments & Advisory/Medicinia Digital MedicineSão Paulo, Brazil

SAM BRASCHDirectorKaiser Permanente VenturesOakland, CA

JOHN BRODSKYPresidentFairmount Capital Advisors, Inc .Philadelphia, PA

LUCAS BUCHANANExecutive Vice President, Corporate Development and Commercialization; Executive in Residence Silk Road Medical, Inc .; Warburg PincusSunnyvale, CA

ALEX BUZIKManaging DirectorMTS Health InvestorsNew York, NY

ELIZABETH J. CAMPBELLPrincipalSV Life Sciences Advisors, LLCBoston, MA

NICOLE CARKNERExecutive DirectorQuad City Health InitiativeDavenport, IA

EDWARD CHANSenior AssociateNaviMed CapitalRosslyn, VA

WILLS CHANDLERVice President of Health System AllianceCVS CaremarkCumberland, RI

DEEP CHARAN, MDResident PhysicianUCLALos Angeles, CA

THIERRY CHAUCHÉExecutive Director, Business Planning & AnalysisNovartis PharmaceuticalsEast Hanover, NJ

EMILY COUEIGNOUX CHENSenior Manager, Market PlanningSeattle GeneticsBothwell, WA

MARK CHINVice PresidentLongitude CapitalMenlo Park, CA

BRIAN G. CHOI, MDAssociate Professor of Medicine & RadiologyGeorge Washington UniversityWashington, DC

EDDIE CISNEROSVice President, Business DevelopmentDAVITA HEALTHCARE PARTNERSChicago, IL

RYAN COCHRANAssociateNew Leaf Venture PartnersNew York, NY

BRETT COHENCorporate Vice PresidentFresenius Medical CareWaltham, MA

CAROLYN COLACICCOSenior ManagerTriVascularSanta Rosa, CA

DANIEL J. CURRAN, MDVice President, Therapeutic Area LeadTakeda Pharmaceutical CompanyCambridge, MA

JAY DESAIEntrepreneurPatientPingBoston, MA

SALIL V. DESHPANDE, MDChief Medical OfficerUnitedHealthcare Community Plan of TexasHouston, TX

Health Care Program MentorsMentors are leaders and senior managers in the health care field who have agreed to provide career and professional development advice and guidance to Health Care Management Students.

2014

continued on next page

Page 30: Wharton _ 2015 Resume Book

303030

PITAMBER “PITOU” DEVGON, MDCo-FounderCreative Vascular, Inc .Philadelphia, PA

CHRIS DUKEExecutive DirectorInternational Commercial RelationsNPS PharmaceuticalsBedminster, NJ

CATHY K. EDDYPresidentHealth Plan AllianceIrving, TX

BRANDON EINSTEINAssociateGoldman SachsNew York, NY

RAMI ELGHANDOURChief Business OfficerNevroMenlo Park, CA

MYRIAN EXUMEDirector, Global CommercializationBristol-Myers SquibbPrinceton, NJ

DANIEL FAGAPrincipalCenterview PartnersSan Francisco, CA

MING FANGPrincipalSafeguard Scientifics, Inc . Wayne, PA

MICHAEL FAZEKASVice PresidentFlexpoint Ford, LLCChicago, IL

EVAN S. FIELDSTON, MDAssistant Professor of Pediatrics,Perelman School of Medicine; Attending Physician General Pediatrics,Director Care Model Innovation,The Children’s Hospital of PhiladelphiaPhiladelphia, PA

DOUGLAS C. FISHER, MDPartnerInterWest PartnersMenlo Park, CA

PETER FISHMANFounderTolographNew York, NY

AARON FLINKSr . Manager, Corp . Strategy and Business DevelopmentMcKessonSan Francisco, CA

CHRIS FRANCKPartner, Life Sciences & Health CareDeloitte Consulting, LLPParsippany, NJ

SARAH FREWDirector, Business and Commercial DevelopmentTetralogic PharmaceuticalsMalvern, PA

MIHIR C. GANDHIDirector, Healthcare Venture InvestmentsAVIA Innovation AcceleratorChicago, IL

MICHAL GATTNARManaging DirectorPavis CapitalMill Valley, CA

SIMEON J. GEORGE, MDPartnerSR One LtdSan Francisco, CA

KYLE GILBRIDESenior AssociateHEALTHAGEN, a subsidiary of AetnaNew York, NY

LETICIA LAZARIDIS GOLDBERGInvestment ManagementEarnest Partners - Brazil OfficeRio de Janeiro, Brazil

BRIAN P. GOLDSTEIN, MDExecutive Vice President and Chief Operating OfficerUNC HospitalsChapel Hill, NC

VIKAS GOYALAssociateSR One Cambridge, MA

TODD GURENProduct Development ManagerProvidence Health PlansPortland, OR

PHILIP GUTRYPrincipalMPM CapitalSouth San Francisco, CA

JOHN HARRISPrincipalDGA PartnersBala Cynwyd, PA

BOSUN HAUPartnerMVM Life Science PartnersBoston, MA

DAVID HECHTVice PresidentFormation CapitalAlpharetta, GA

PHIL HEIFETZPresident and CEOEyelC, Inc .W . Conshohocken, PA

CARRIE HIEBELERSenior Investment OfficerVentas, Inc .Chicago, IL

VLAD HOGENHUIS, MDSenior Vice President, Global Franchise Leader CardioVascularGlaxoSmithKlineBrentford, UK

SAM HOLLIDAYVice President, Corporate Development & StrategyEveryday HealthNew York, NY

TODD HOLMESDirectorGurnet Point CapitalBoston, MA

BRIAN HOLZERSenior Vice President, Diversified BusinessesAllegheny Health NetworkPittsburgh, PA

JARED HOPKINSDirector Strategic Finance and Business ConsultingUniversity of Michigan Health SystemAnn Arbor, MI

NOUHAD HUSSEINISenior Director, Business DevelopmentRegeneron PharmaceuticalsTarrytown, NY

EMILY COOPER JANVEYVice PresidentTPG Special Situations PartnersSan Francisco, CA

MAGGIE HILL JARRETTSenior Manager, Corporate Strategy & Business DevelopmentMcKessonDenver, CO

PRASHANTH JAYARAMHealthcare AnalystCitadel GroupNew York, NY

VIVEK K. JAYARAMANVice President – Global Sales & MarketingTriVascular, Inc .Santa Rosa, CA

TRACY K. JOHNSONVice PresidentHealth Strategies and SolutionsPhiladelphia, PA

FABIO ALEXANDRE JUNGDirector/Investment Banking BrazilDeutsche BankSão Paulo, Brazil

KARL M. KELLNERDirectorMcKinsey & Company, Inc .New York, NY

Health Care Program Mentors

Page 31: Wharton _ 2015 Resume Book

31

RON C. KEROVice President, Business Development & OperationsVHA West Coast Insurance & Financial ServicesRenton, WA

RUHI KHANVice President, Business DevelopmentAcorda TherapeuticsHawthorne, NY

DAVID KIBBEDivisional Vice President, Acute CareUniversal Health ServicesKing of Prussia, PA

MIKE KIJEWSKIFounder Gamma BasicsCarlsbad, CA

JOYCE KIMSenior Managerial ConsultantKaiser Permanente VenturesOakland, CA

STEPHEN KIMAssociateGoldman, Sachs & Co .New York, NY

RYAN KIRKPATRICKPartnerColorado Impact FundDenver, CO

DAVE KONCIAKDirector, Strategic AnalyticsBristol-Myers Squibb Lawrenceville, NJ

ADAM M. KOPPEL, MD, PHDChief Strategy Officer & Senior Vice PresidentBiogen IdecBoston, MA

MICHELLE LEEConsultantKaiser Permanente Performance ExcellenceSan Francisco, CA

RICHARD LEE, MDAssistant ProfessorWeill Cornell Medical CollegeNew York, NY

ELIZABETH LEIDERMAN, MDVice PresidentNomura New York, NY

ADAM LESSLEREngagement ManagerMcKinsey & CompanyPhiladelphia, PA

MICHAEL LIPortfolio ManagerAmerican Century InvestmentsKansas City, MO

OSCAR LINAnalystAxial CapitalNew York, NY

LAUREN LISHERSenior DirectorRelayHealth/McKesson CorporationEmeryville, CA

WENDY LIUVice PresidentHealthCare Royalty PartnersStamford, CT

MARK A. LYLES, MDChief Strategic OfficerMedical University of South CarolinaCharleston, SC

CAROLYN MAGILLSenior Vice President, Payer Strategy & OperationsEvolent HealthArlington, VA

JEFFREY D. MARRAZZOPresident and CEOSpark Therapeutics Inc .Philadelphia, PA

ALISON MARXOperating Officer, Dept . of PediatricsThe Children’s Hospital of PhiladelphiaPhiladelphia, PA

GREGG MCCONNELLSr . Manager, Business DevelopmentPfizerNew York, NY

ROBERT C. MCDONALD, MDPresidentAledo Consulting, Inc .Indianapolis, IN

REGAN MURPHYChief of Staff / Client ManagerValence HealthChicago, IL

HAREESH NAIRVice PresidentQuadria Capital Investment Mgmt . Pte LtdSingapore

DAVID B. NASH, MDDean, Jefferson School of Population HealthThomas Jefferson UniversityPhiladelphia, PA

TY NELSONExecutive Vice President OperationsHealth Carousel LLCCincinnati, OH

PRASHANT NIKAMDirector, Global Commercial Leader, Mozobil & Legacy BrandsSanofiCambridge, MA

TATIANA NIKITINAChief Marketing OfficerxG Health SolutionsNew York, NY

PRIYA NILEKANISenior Managerial ConsultantKaiser PermanenteOakland, CA

WESLEY NURSSAssociateISI GroupNew York, NY

JAMES O’CONNELLPrincipal Safeguard Scientifics, Inc .Wayne, PA

JENNIFER O’NEILLBrand Manager, EffientDaiichi Sankyo Inc .Parsippany, NJ

CARY PFEFFER, MDPartnerThird Rock VenturesBoston, MA

GARY M. PHILLIPS, MDSenior Vice President and Chief Strategy OfficerMallinckrodt PharmaceuticalsHazelwood, MO

JOHN PICASSOSenior AssociateFifth Street Management LLCWhite Planis, NY

SALLY POBLETEFounder and CEOWellthie Inc .New York, NY

LEN PODOLSKYDirector of OperationsConnolly, LLCConshohocken, PA

AMIKA PORWALSenior AssociateBooz & CompanyChicago, IL

KEVIN PYUNManaging DirectorConsonance Capital InvestorsNew York, NY

LISA RAMONHealth Systems and Services Expert for Latin AmericaMcKinsey & CompanyMexico City, Mexico

LINDSAY RANDSenior Manager, Strategic Initiatives OfficeUniversity of Chicago MedicineChicago, IL

DONNA BRADY RAZIANO, MDChief Medical OfficerMercy Home System, Mercy Home and Community Health ServicesPhiladelphia, PA

ERIC REDLINEVice President Client DeliveryPharma MetricsFort Washington, PA

JOSHUA RESNICK, MDVenture Partner, Atlas Venture;CEO, Ataxion TherapeuticsCambridge, MA

continued on next page

Page 32: Wharton _ 2015 Resume Book

32

BEN RHEESenior Manager – Life Sciences StrategyAccenturePhiladelphia, PA

JAMES RHODESSenior ConsultantDeloitte Consulting LLPDallas, TX

JAMES F. RICHTERVice PresidentBusiness DevelopmentRedMedPaoli, PA

SAFIA K. RIZVIManaging Director UCB India Private LimitedMumbai, India

EDMONDO J. ROBINSON, MDAssociate Chief Medical Officer, Physician in ChiefChristiana Care Health SystemWilmington, DE

PAMELA RODMANAdministrative DirectorColumbia UniversityNew York, NY

BENJAMIN ROOKSManaging DirectorST Advisors, Inc .San Francisco, CA

MICHAEL ROVINSKYExecutive Director, Strategic PlanningKaiser Permanente of the Mid-Atlantic StatesRockville, MD

ANIL SAGGIM&A DirectorNovartisStockholm, Sweden

DAVID SCHUPPANPartnerCressey & Company LPChicago, IL

SVEN SEYFFERTSenior Business DirectorMedtronicSingapore

AMIT B. SHAH, MDAssociate PrincipalMcKinsey & CompanyNew York, NY

ANKIT SHAHSr . Marketing ManagerIntersect ENTMenlo Park, CA

JONATHAN SHANNONExecutive DirectorUniversal American (Collaborative Health Systems)Atlanta, GA

SHAFINA SHEHNAZVice PresidentGoldman Sachs & Co .New York, NY

DAVID SILKDirector Digital Acceleration, US MarketingPfizerNew York, NY

ANNE SISSELVice PresidentDean Bradley OsborneSan Francisco, CA

JONTHAN SOLOMONSPresident & CEOTabor Children’s ServicesPhiladelphia, PA

MAUREEN A. SPIVACKManaging DirectorKPMG Corporate Finance LLCNew York, NY

BHUVAN SRINIVASANAssociateKKRMumbai, India

JAMES STANFORDPrincipalFitzroy HealthUpper Montclair, NJ

MEIR STEINDirector of Marketing DevelopmentSatellite HealthcareSan Jose, CA

JÉRÔME STEVENS, MDCEOPatientys (subsidiary of Direct Medcica Group)Boulogone, France

SCOT STEVENSPublic Equity PartnerOrbi Med Advisors LLCNew York, NY

PATRICK SULLIVANVice PresidentGMT Capital Corp .New York, NY

RUTH SUTERSenior Director, Market Access and Patient ServicesBioMarin Pharmaceutical Inc .Novato, CA

VIC TANDONSr . Manager, Health and IT StrategyWest Health InstituteLa Jolla, CA

JARED TEOSr . Program OfficerCalifornia Health Care FoundationSan Francisco, CA

PAUL V. THOMASBusiness Unit Head – BiosimilarsBiocon Ltd .Bangalore, India

PAUL TIRJANVice President, Ambulatory CareUniversal Health Services, Inc .King of Prussia, PA

AMANDA HOPKINS TIRRELLChief Operating OfficerGeorgia Regents Medical Associates,Medical College of GeorgiaAugusta, GA

ERIC TRÉPANIERVice President, Commercial Clinical Strategy & AnalyticsWebMD/MedscopeNew York, NY

JOHN URQUHARTSenior AssociateHealthCare Royalty PartnersStamford, CT

LISA VARSHNEYAssociate PartnerRosetta Marketing Strategy & Insights PracticeNew York, NY

DAVID WALTONChief Commercial OfficerAgaMatrixSalem, NH

JASON WEIDMANVice President and General Manager,Medtronic Coronary VascularMedtronicSanta Rosa, CA

CHRIS WILKERSONPresidentEquipSystems, LLCNew York, NY

JOHN WINKELMANPresidentWinkelman Associates Inc .Irvine, CA

ANDREW W. WONGVice President, Business DevelopmentSciClone Pharmaceuticals, Inc .Shanghai, China

DANIEL YIPSenior Director, Global MarketingIntercept PharmaceuticalsNew York, NY

STEPHEN E. YODER, MDGlobal Lead, CV/Metabolic Search & Evaluation, Bus . Dev .Bristol-Myers SquibbPrinceton, NJ

ELLEN S. YOONGlobal Health Care Subject Matter ExpertIBM Corp .New York, NY

KEELY ZIPPDirector Oncology Operations,Global Oncology FranchiseGlaxoSmithKlineCollegeville, PA

THOMAS ZIPPGlobal Brillinta Business Insight Lead, BrillintaAstraZenecaWilmington, DE

Page 33: Wharton _ 2015 Resume Book

33

GEOFFREY M. GARRETT, PH.D.Dean, The Wharton School

HOWARD KAUFOLD, PH.D.Vice Dean and Director,The Wharton Graduate Division

SCOTT E. HARRINGTON, PH.D.Chair, Health Care Management Department, The Wharton School;Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A.Associate Director,MBA Program in Health Care Management

CHRISTINE ALESZCZYKAdministrative Coordinator,MBA Program in Health Care Management

JANICE SINGLETONAdministrative Coordinator,MBA Program in Health Care Management

Administration

Page 34: Wharton _ 2015 Resume Book

34

The Program Faculty are drawn from

the Wharton School, the School of

Medicine, the School of Nursing, and

the School of Arts and Sciences at the

University of Pennsylvania and leading

health institutions in Philadelphia.

Additional support is provided by the

Fellows and Associates of the Leonard

Davis Institute of Health Economics.

EUGENIO ANESSI, PH.D.Professor, Public Management, Bocconi University Graduate School of Management, Milan, Italy; Lecturer and Senior Fellow, Health Care Management, The Wharton School

DAVID A. ASCH, M.D., M.B.A.Executive Director, Penn Medicine Center for Health Care Innovation;Professor of Medicine,Perelman School of Medicineat the University of Pennsylvania;Professor, Health Care Management, The Wharton School

THOMAS E. BAKER, J.D.William Maul Measey Professor of Law and Health Sciences, University of Pennsylvania Law School;Professor of Health Care Management, The Wharton School

LAWTON R. BURNS, PH.D., M.B.A.James Joo-Jin Kim Professor of Health Care Management, The Wharton School;Faculty Co-Director, Roy and Diana Vagelos ProgramIn Life Sciences & Management

PATRICIA M. DANZON, PH.D.Celia Z . Moh Professor of Health Care Management and Business Economics, The Wharton School

GUY DAVID, PH.D.Associate Professor, Health Care Management, The Wharton School

BENJAMIN DORANZ, PH.D., M.B.A.President and CEO, Integral Molecular, Inc .; Senior Fellow, Health Care Management, The Wharton School

EZEKIEL J. EMANUEL, M.D., PH.D.Diane v .S . Levy and Robert M . Levy University Professor and Vice Provost for Global Initiatives;Professor, Health Care Management,The Wharton School

ROBERT I. FIELD, J.D., PH.D., M.P.H.Professor of Law at the Earle Mack School of Law and Professor of Health Management and Policy at the School of Public Health at Drexel University, Philadelphia; Lecturer, Health Care Management, The Wharton School

BRADLEY M. FLUEGELSenior VP & Chief Strategy Officer, Walgreens; Lecturer, Health Care Management, The Wharton School

THOMAS N. GILMORE, M.ARCH. Vice President, The Center for Applied Research Inc .;Senior Fellow, Health Care Management, The Wharton School

JOHN P. GLASER, PH.D.Chief Executive Officer, Health Systems Business Unit, Siemens; Lecturer, Health Care ManagementThe Wharton School

HENRY A. GLICK, PH.D.Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

MATTHEW R. GRENNAN, PH.D.Assistant Professor, Health Care Management,The Wharton School

SCOTT E. HARRINGTON, PH.D.Chair, Health Care Management Department, and Director, Health Care Management Program, The Wharton SchoolAlan B . Miller Professor of Health Care Management and Business Economics and Public Policy, The Wharton School

JOHN C. HERSHEY, PH.D.Anheuser-Busch Professor Emeritusof Management Science; andHealth Care Management,The Wharton School

NAOKI IKEGAMI, M.D.Professor, Keio University School of Medicine, Tokyo, Japan; Senior Fellow, Health Care Management, The Wharton School

JOHN KIMBERLY, PH.D.Henry Bower Professor of Entrepreneurial Studies; Professor of Management, Health Care Management, and Sociology, The Wharton School

JUNE M. KINNEY, M.A. Associate Director, Graduate Program in Health Care Management;Lecturer, Health Care Management, The Wharton School

JONATHAN T. KOLSTAD, PH.D.Assistant Professor, Health Care Management, The Wharton School

GARY J. KURTZMAN, M.D.Vice President, Life Sciences, Safeguard Scientifics; Lecturer, Health Care Management, The Wharton School

JEFFREY P. LIBSON, J.D.Partner, Pepper Hamilton LLP; Lecturer, Health Care Management, The Wharton School

HARI MAHADEVAN, PH.D.Independent Consultant; Lecturer and Senior Fellow, Health Care Management, The Wharton School

DANIEL N. MENDELSON. M.P.P.CEO and Chairman, Avalere Health Inc .; Lecturer, Health Care Management; The Wharton School

STEVEN A. NICHTBERGER, M.D.Adjunct Professor and Senior Fellow, Health Care Management, The Wharton School

MITESH S. PATEL, M.D.Assistant Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania School of Medicine;Assistant Professor of Health Care Management, The Wharton School

MARK V. PAULY, PH.D.John M . and Thomas L . Bendheim Professor; Professor, Health Care Management, Business Economics and Public Policy, The Wharton School; Professor, Economics, College of Arts and Sciences

WILLIAM P. PIERSKALLA, PH.D.Professor Emeritus

DANIEL POLSKY, PH.D.Robert D . Eilers Professor of Health CareManagement and Economics, The Wharton School;Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Executive Director, Leonard DavisInstitute of Health Economics

Faculty

Page 35: Wharton _ 2015 Resume Book

35

DOUGLAS A. PRESENT, M.B.A.Independent Consultant; Lecturer, Health Care Management, The Wharton School

ARNOLD J. ROSOFF, J.D.Professor Emeritus, Legal Studies and Business Ethics;Lecturer, Health Care Management,The Wharton School

STEPHEN M. SAMMUTLecturer and Senior Fellow, Health Care Management, Lecturer, Entrepreneurial Programs, The Wharton School

CYNTHIA SCALZI, M.N., PH.D.Professor Emeritus of Nursing and Health Care Management,The Wharton School

J. SANFORD SCHWARTZ, M.D.Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY H. SILBER, M.D., PH.D.Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management,The Wharton School

JEFFREY A. SOLOMON, M.D., M.B.A.Founding Partner, Infiniti Medical LLC;Lecturer, Health Care Management,The Wharton School

AMANDA STARC, PH.D.Assistant Professor, Health Care Management, The Wharton School

ASHLEY SWANSON, PH.D.Assistant Professor, Health Care Management,The Wharton School

ROBERT J. TOWN, PH.D.Associate Professor, Health Care Management The Wharton School

KEVIN G.M. VOLPP, M.D., PH.D.Director, Center for Health Incentives and Behavioral Economics, Leonard Davis Institute;Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

SCOTT E. HARRINGTON, PH.D.Director,MBA Program in Health Care Management,The Wharton School

JUNE KINNEYAssociate Director, MBA Program in Health Care ManagementThe Wharton School

The University of Pennsylvania values diversity and seeks talented students, faculty and staff from diverse backgrounds . The University of Pennsylvania does not discriminate on the basis of race, sex, sexual orientation, gender identity, religion, color, national or ethnic origin, age, disability, or status as a Vietnam Era Veteran or disabled veteran in the administration of educational policies, programs or activities; admissions policies; scholarship and loan awards; athletic, or other University adminis-tered programs or employment .

Questions or complaints regarding this policy should be directed to:

Executive Director,Office of Affirmative Action and Equal Opportunity ProgramsSansom Place East3600 Chestnut Street, Suite 228 Philadelphia, PA 19104-6106215 .898 .6993 (Voice)215 .898 .7803 (TDD)

©2004, The Trustees of the University of Pennsylvania . All rights reserved .

Photography of Students: Stuart WatsonBook Design: www.HollisterCreative.com

RACHEL M. WERNER, M.D., PH.D Associate Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania School of Medicine; Associate Professor and Senior Fellow, Operations and Information Management, Health Care Management, The Wharton School

JOHN J. WHITMAN, M.B.A.Executive Director, The TRECS Institute; Lecturer, Health Care Management, The Wharton School

SANKEY V. WILLIAMS, M.D.Sol Katz Professor of General Internal Medicine; Professor, Health Care Management, The Wharton School

Page 36: Wharton _ 2015 Resume Book

WhartonThe Wharton School University of Pennsylvania

MBA Program in Health Care Management3641 Locust WalkPhiladelphia, PA 19104-6218

215 .898 .6861fax 215 .573 .2157